<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29213239</article-id>
<article-id pub-id-type="pmc">5702851</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2017.00854</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Dynamic Editome of Zebrafish under Aminoglycosides Treatment and Its Potential Involvement in Ototoxicity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Sijia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn005">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/466009/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Yulan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn005">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/497663/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Lin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Xinzhi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Lihua</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Huizhong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/497532/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Menglin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/497667/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Su</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/497690/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cao</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tian</surname>
<given-names>Weidong</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xing</surname>
<given-names>Qinghe</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/497543/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Institutes of Biomedical Sciences and Children's Hospital, Fudan University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Children's Hospital, Fudan University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Zhengzhou People's Hospital</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Zhengzhou Central Hospital, Zhengzhou University</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Biostatistics and Computational Biology, School of Life Science, Fudan University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Wanqing Liu, Wayne State University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Maria J. Prata, Ipatimup, Portugal; Meenal Gupta, University of Utah, United States</p>
</fn>
<corresp id="fn001">*Correspondence: Wei Cao <email xlink:type="simple">caoweiyu@hotmail.com</email></corresp>
<corresp id="fn002">Weidong Tian <email xlink:type="simple">weidong.tian@fudan.edu.cn</email></corresp>
<corresp id="fn003">Qinghe Xing <email xlink:type="simple">xingqinghe@hotmail.com</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Pharmacogenetics and Pharmacogenomics, a section of the journal Frontiers in Pharmacology</p>
</fn>
<fn fn-type="other" id="fn005">
<p>†These authors have contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>854</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Yan, Lu, He, Zhao, Wu, Zhu, Jiang, Su, Cao, Tian and Xing.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Yan, Lu, He, Zhao, Wu, Zhu, Jiang, Su, Cao, Tian and Xing</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>RNA editing is an important co- and post-transcriptional event that generates RNA and protein diversity. Aminoglycosides are a group of bactericidal antibiotics and a mainstay of antimicrobial therapy for several life-threatening infections. However, aminoglycosides can induce ototoxicity, resulting in damage to the organs responsible for hearing and balance. At low concentrations, aminoglycosides can bind to many RNA sequences and critically influence RNA editing. We used a bioinformatics approach to investigate the effect of aminoglycosides on global mRNA editing events to gain insight into the interactions between mRNA editing and aminoglycoside ototoxicity. We identified 6,850 mRNA editing sites in protein coding genes in embryonic zebrafish, and in about 10% of these, the degree of RNA editing changed more than 15% under aminoglycosides treatment. Twelve ear-development or ototoxicity related genes, including <italic>plekhm1, fgfr1a, sox9a</italic>, and <italic>calrl2</italic>, exhibited remarkable changes in mRNA editing levels in zebrafish treated with aminoglycosides. Our results indicate that aminoglycosides may have a widespread and complicated influence on the progress of mRNA editing and expression. Furthermore, these results highlight the potential importance of mRNA editing in the pathogenesis and etiology of aminoglycoside-induced ototoxicity.</p>
</abstract>
<kwd-group>
<kwd>zebrafish</kwd>
<kwd>RNA-editing</kwd>
<kwd>RNA-Seq</kwd>
<kwd>aminoglycosides (AG)</kwd>
<kwd>ototoxicity</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source>
<award-id rid="cn001">31371274</award-id>
<award-id rid="cn001">31611130035</award-id>
<award-id rid="cn001">81171992</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Science and Technology Commission of Shanghai Municipality<named-content content-type="fundref-id">10.13039/501100003399</named-content></funding-source>
<award-id rid="cn002">14DJ1400100</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="5"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="87"></ref-count>
<page-count count="13"></page-count>
<word-count count="10159"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>RNA editing is a co- and post-transcriptional mechanism of introducing changes into RNA sequences encoded by the genomic blueprint. RNA editing finely regulates gene function including splicing, localization, translation, and transcript stability. The most common type of RNA editing in metazoans is the conversion of adenosine to inosine, which is translated as guanosine [A-to-I (G)]. This change is carried out by adenosine deaminases that act on RNA (ADARs) proteins, a family of double stranded RNA (dsRNA) binding enzymes. Consequently, these modifications can alter codon identity and increase genetic diversity (Nishikura, <xref ref-type="bibr" rid="B47">2010</xref>). In human, A-to-I (G) editing sites are mostly located in Alu repeats, and are essential for the normal physiology of cells (Wang et al., <xref ref-type="bibr" rid="B81">2013</xref>; Porath et al., <xref ref-type="bibr" rid="B54">2014</xref>). Moreover, this mechanism is not static, and shows continuous dynamic change in different tissues and development stages to fine-tune and optimize biological pathways (Mehler and Mattick, <xref ref-type="bibr" rid="B43">2007</xref>; Hwang et al., <xref ref-type="bibr" rid="B25">2016</xref>; Qiu et al., <xref ref-type="bibr" rid="B56">2016</xref>).</p>
<p>RNA editing level basically maintained within normal range is an essential mechanism to maintain normal physiological function. The deregulation of RNA editing may contribute to neurological diseases such as epilepsy, depression, schizophrenia, autism, fragile-X syndrome, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (Akbarian et al., <xref ref-type="bibr" rid="B1">1995</xref>; Kawahara et al., <xref ref-type="bibr" rid="B32">2004</xref>; Maas et al., <xref ref-type="bibr" rid="B42">2006</xref>; Gallo et al., <xref ref-type="bibr" rid="B13">2017</xref>). The editing sites in <italic>AZIN1</italic> play an important role in hepatocellular carcinoma tumorigenesis, and two editing sites in <italic>COG3</italic> and <italic>SRP9</italic> have been reported in a breast cancer study (Shah et al., <xref ref-type="bibr" rid="B67">2009</xref>; Chen et al., <xref ref-type="bibr" rid="B4">2013</xref>). Therefore, RNA editing deficiencies or hyperactivity may be associated with additional, as yet undiscovered, pathological mechanisms.</p>
<p>ADARs recognize dsRNA substrates characterized by loops and bulges (Wong et al., <xref ref-type="bibr" rid="B85">2001</xref>), and ADAR2 preferentially binds imperfect RNA fold-back structures (Klaue et al., <xref ref-type="bibr" rid="B35">2003</xref>). Numerous results suggest that RNA is a major biological target of aminoglycosides (AG; Vicens and Westhof, <xref ref-type="bibr" rid="B80">2003</xref>). AG are clinically important antibiotics despite their unwanted side effects of ototoxicity and nephrotoxicity (Rizzi and Hirose, <xref ref-type="bibr" rid="B60">2007</xref>). AG exert their antibiotic effects through binding to the A site of bacterial 16S rRNA (Kaul and Pilch, <xref ref-type="bibr" rid="B31">2002</xref>). Moreover, positively charged amino groups facilitate AG docking to negatively charged pockets in RNA folds (Hermann and Westhof, <xref ref-type="bibr" rid="B23">1999</xref>). Direct observation of AG–RNA interactions shows that neomycin B generally binds to regular A-form RNA or hairpin loops (Hendrix et al., <xref ref-type="bibr" rid="B22">1997</xref>). Therefore, neomycin B has been used as a positive control in the inhibition of ADAR2-catalyzed editing of certain substrates (Schirle et al., <xref ref-type="bibr" rid="B65">2010</xref>). Given that dsRNA is the substrate of RNA editing and AG binding, we hypothesized that AG may interfere with, or change, normal RNA editing.</p>
<p>Zebrafish embryos possess transparent bodies, making it easy to observe structural changes. Moreover, the lateral line hair cells of zebrafish share essential properties with human inner ear hair cells, and thus they are often used as a model for studying drug toxicity (Kari et al., <xref ref-type="bibr" rid="B30">2007</xref>). Earlier studies only identified a handful of RNA editing sites in zebrafish (Sie and Maas, <xref ref-type="bibr" rid="B69">2009</xref>; Pozo and Hoopengardner, <xref ref-type="bibr" rid="B55">2012</xref>; Li et al., <xref ref-type="bibr" rid="B40">2014</xref>). A recent study identified more than 300 thousands of clustered RNA editing sites in the zebrafish covering eight different developmental stages, in which 5,460 editing sites were detected in the gene coding sequences (Shamay-Ramot et al., <xref ref-type="bibr" rid="B68">2015</xref>). However, the global extent of editome changes in gene body of zebrafish embryos after treatment with AG has not yet been investigated.</p>
<p>In principle, RNA editing sites can be inferred based on sequence differences between RNA (or cDNA) and the genomic DNA from which it is expressed. Here, we focused on mRNA editing sites because mRNA plays a critical role in the central dogma of molecular biology. We firstly identified post-transcriptional editing events in control or AG treated zebrafish using both mRNA-seq and DNA-seq. DNA-seq data was used to filter the DNA variants. mRNA-seq data were analyzed by a novel bioinformatic pipeline aimed at detecting hyper RNA editing sites (Zhang et al., <xref ref-type="bibr" rid="B87">2017</xref>). Our improved approach revealed 6,850 mRNA editing sites in gene body regions, including coding sequences (CDS), untranslated regions (UTR), and introns. Our results provide a survey of the variation in mRNA editing rates after treatment with ototoxic drugs, such as AG. As the precise mechanism of AG-induced ototoxicity has not yet been fully elucidated, determining the global and dynamic aspects of the editome and transcriptome under AG treatment could inform a new area of research and provide new insights into the epitranscriptional regulation of sequence diversity.</p>
</sec>
<sec id="s2" sec-type="materials and methods">
<title>Materials and methods</title>
<sec>
<title>Animals</title>
<p>Zebrafish (AB line, standard length: 2.7–3.5 cm) were raised in a recirculating water system according to standard protocols (Westerfield, <xref ref-type="bibr" rid="B83">2000</xref>). Aquaria-system water was dosed to a salinity of 500 μF with artificial ocean salt mix and buffered to pH 7.2 with NaHCO<sub>3</sub>. After the group mating of four male and four female adult zebrafish (aged 6 months post-fertilization), embryos were collected and raised at 28.5°C in embryo medium (EM) at a density of 35–40 embryos per 10-cm diameter Petri dish. EM was prepared as previously reported (Coffin et al., <xref ref-type="bibr" rid="B5">2009</xref>). Embryos were staged by hours post-fertilization (hpf) and days post-fertilization (dpf) as described previously (Kimmel et al., <xref ref-type="bibr" rid="B33">1995</xref>). This study was carried out in accordance with the recommendations of the Fudan University Institutional Animal Care and Use Committee's guidelines (20120302-065). The protocol was approved by the Fudan University Institutional Animal Care and Use Committee.</p>
</sec>
<sec>
<title>Aminoglycoside treatment</title>
<p>Neomycin (5 g stock) or gentamicin (5 g stock; Sangon Biotech) was diluted in EM to final concentrations of 200 μM, or 25 and 50 μM, respectively. AG exposure paradigms were based on prior observations of the zebrafish lateral line (Owens et al., <xref ref-type="bibr" rid="B49">2009</xref>; Stengel et al., <xref ref-type="bibr" rid="B73">2017</xref>).</p>
<p>Healthy staged embryos were incubated from the 50% epiboly of embryonic shield stage (5.25 hpf) in neomycin or gentamicin to the long-pec stage during the hatching period (2 dpf). The medium was changed every 24 h. There was no statistical difference in embryo mortality between the exposed groups and control groups during this period. The 2 dpf zebrafish embryos were rinsed with EM several times and transferred to EM for further observation. The control groups were raised in EM the entire time, and the EM was changed every 24 h. Hair cell damage was examined in zebrafish embryos at 2 and 4 dpf.</p>
<p>Hair cells were pre-labeled with the mechanotransduction marker FM1-43 FX (3 μM in standard aquaria system water; Invitrogen Molecular Probes) for 45–60 s. The embryos were then quickly rinsed three times with EM. Using this procedure, FM1-43 FX is restricted to hair cells in neuromasts (Seiler and Nicolson, <xref ref-type="bibr" rid="B66">1999</xref>). Hair cell survival was denoted by FM1-43 FX-positive cytoplasm surrounding the nucleus and an intact cell morphology.</p>
<p>Embryos were anesthetized with 0.001% MS-222 (Sigma). Zebrafish observations and image capture were conducted on a Zeiss Discovery V.20 microscope with a GFP filter set and an AxioCamHRc camera (Carl Zeiss), to visualize FM1-43 FX. Image stack projections or single image slices were exported from Slidebook software v. 4 (Olympus).</p>
</sec>
<sec>
<title>RNA isolation and deep sequencing</title>
<p>Total RNA for each sample was collected from 30 to 35 embryos at 2 dpf. Total RNA was isolated using Trizol reagent (Life Technologies). Agilent 2100 Bioanalyzer was used to characterize <italic>in vitro</italic> RNA transcripts for quality. The RNA integrity numbers (Rin) of all samples were higher than 8.0. The poly-A-containing mRNA molecules were purified using poly-T oligo-attached magnetic beads using two rounds of purification. A SuperScript Double-Stranded cDNA Synthesis kit (Invitrogen) was used to synthesize the double-stranded cDNA. Further library preparation was performed using TruSeq™ RNA Sample Preparation Kit (Illumina, cat# FC-122-1001). Libraries were sequenced as SR 2 × 100 bp using Illumina Hiseq2000 according to the manufacturer's instructions. We removed adaptor, low-complexity, and low-quality sequences in the raw reads. The remaining clean reads were used for further analyses.</p>
</sec>
<sec>
<title>DNA sequencing of zebrafish</title>
<p>Genomic DNA was isolated from the whole bodies of the four male and four female adult zebrafish from the mating pool using the DNeasy Blood &amp; Tissue Kit (Qiagen) according to the manufacturer's instructions. Equal amounts of total DNA from each zebrafish were pooled into a single sample. About 5 μg genomic DNA was sheared into fragments of 200–250 bp using a Covaris focused acoustic sonicator (Covaris, MA, USA). After size selection of fragments by 2% agarose gel electrophoresis, we constructed paired-end libraries with the NEXTflex DNA Sequencing Kit (BIOO Scientific, TX, USA) and Illumina adaptors using 1 μg of sheared input DNA. All libraries were sequenced on the Illumina Hiseq 2500 platform (Illumina Inc., CA, USA). After filtering out adaptor sequences, low-quality reads, and duplicate reads, a total of 54,802 Gb of data was retained for assembly.</p>
</sec>
<sec>
<title>Variant calling</title>
<p>The first 10 nts of paired-end reads were trimmed and filtered using a sequencing quality score cut-off of 30 for each RNA-seq dataset. Filtered reads were then aligned against the zebrafish reference genome (UCSC danRer7) with the Burrows-Wheeler Aligner program (BWA, version 0.7.12) using the default parameters (Li and Durbin, <xref ref-type="bibr" rid="B38">2009</xref>). For each DNA-seq dataset, the first 10 nts of paired-end reads were also trimmed before being aligned against the reference genome with BWA. After mapping, the Samtools mpileup function was used to remove PCR duplicates, sort the alignment file, and call variants using default parameters for both RNA-seq and DNA-seq datasets (Li et al., <xref ref-type="bibr" rid="B39">2009</xref>).</p>
<p>To improve the efficiency and accuracy of the discovery of RNA editing sites, we applied data quality filtration criteria during the three major steps of the analysis. Firstly, we took variant positions in the RNA into consideration if they varied from the reference genome and met our requirements in terms of the number, frequency, and quality of bases. We specifically required that the read coverage was at least 10, the mapping quality score of covered reads was at least 20, and there were at least two reads to support the alternative allele (Shamay-Ramot et al., <xref ref-type="bibr" rid="B68">2015</xref>). Secondly, all homozygous and heterozygous DNA variants identified from DNA-seq data were filtered. Variants located within intergenic regions, polymers longer than 5 nts, or simple repeat regions, as well as known zebrafish SNPs in dbSNP (database version 135; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/">http://www.ncbi.nlm.nih.gov/SNP/</ext-link>) and Ensembl variants annotated in Zv9 were also filtered. Thirdly, to further reduce false positives and identify RNA editing variants, we used the RNA-editing Calling process from a recently published method called SPRINT, which uses the editing type and cluster information of potential RNA editing sites to further enhance the calling power (Zhang et al., <xref ref-type="bibr" rid="B87">2017</xref>).</p>
</sec>
<sec>
<title>Recalling and comparing the degree of editing</title>
<p>To demonstrate differences in RNA editing among various treatments, all candidate RNA editing sites were combined as a candidate group, and then the sequencing statuses of these sites were re-evaluated with Samtools. For each different treatment, we calculated the ratio of edited sites for each replicated sample and determined the mean value of the treatment group. The degree of editing for a given site was calculated as the ratio of reads supporting the edited base to the total number of reads covering the site.</p>
</sec>
<sec>
<title>Validation of sites with PCR and sanger sequencing and sequence logo generation</title>
<p>PCR amplification of gDNA and cDNA was carried out with the GeneAmp® PCR System 9700 (Thermo Fisher Scientific, MA, USA). The PCR protocol was as follows: 95°C for 4 min; 30 cycles of 94°C for 30 s, 57°C for 30 s, and 72°C for 30 s; 72°C for 10 min; followed by storage at 4°C as necessary. Direct sequencing was performed using an ABI 3730 DNA Analyzer (Applied Biosystems, MA, USA). The primers used for Sanger sequencing validation of called sites were listed in Supplementary Table <xref ref-type="supplementary-material" rid="SM11">10</xref>. Sequence logos were generated with the program Two sample logo (Vacic et al., <xref ref-type="bibr" rid="B77">2006</xref>).</p>
</sec>
<sec>
<title>Gene expression analysis</title>
<p>Tophat v2.1.0 was used with default parameters to generate acceptable alignments for Cufflinks, in which the RNA-seq paired-end reads were aligned against the reference genome, UCSC danRer7 (Trapnell et al., <xref ref-type="bibr" rid="B76">2012</xref>). Annotated gene expression was evaluated in FPKM (fragments per kilobase per million mapped fragments) using Cufflinks from RNA-seq data. The formula to calculate FPKM was as follows: FPKM = (number of mapping fragments) × 10<sup>3</sup> × 10<sup>6</sup>/ [(length of transcript) × (number of total fragments)]. The method of normalizing expression data for comparison included log transformation and zero-mean normalization. Pathway analysis of genes with mRNA editing sites in zebrafish was performed using PANTHER v.10 (Mi et al., <xref ref-type="bibr" rid="B44">2016</xref>).</p>
</sec>
<sec>
<title>Correlation analysis of expression and editing</title>
<p>The correlation between gene expression and editing was calculated using R software, version 3.1.2 (The R Foundation for Statistical Computing, Vienna, Austria; R Development Core Team, <xref ref-type="bibr" rid="B57">2013</xref>).</p>
</sec>
<sec>
<title>Predicting MicroRNA (miRNA) binding sites</title>
<p>For a given candidate RNA editing site, we used MIRANDA (Enright et al., <xref ref-type="bibr" rid="B11">2003</xref>) to predict potential miRNA binding sites in both the genomic sequence and mRNA sequence after editing. Sequence windows of 50 bp around each editing site were provided to the prediction algorithm.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec>
<title>Establishing a model of AG-induced ototoxicity</title>
<p>To establish a model of AG-induced ototoxicity, embryonic zebrafish were incubated in medium containing various concentrations of AG from the beginning of zebrafish ear development at the 50% epiboly/shield stage to 2 dpf, when the statoacoustic (VIIIth) ganglion becomes a separate section (Haddon and Lewis, <xref ref-type="bibr" rid="B18">1996</xref>; Whitfield et al., <xref ref-type="bibr" rid="B84">2002</xref>). Then, AG-treated zebrafish embryos were cleansed with and transferred to normal EM until 4 dpf, when the mechanoelectrical transducer channels attained maturity (Santos et al., <xref ref-type="bibr" rid="B62">2006</xref>). Analysis of FM1-43 FX hair cell labeling at 2 and 4 dpf revealed that hair cells had differentiated into neuromasts in the head and along the posterior lateral line in the control zebrafish (Kimmel et al., <xref ref-type="bibr" rid="B33">1995</xref>). However, few fluorescently labeled hair cell bundles were observed in the head and lateral line neuromasts of 2 and 4 dpf zebrafish embryos treated with AG (Figures <xref ref-type="fig" rid="F1">1A–H</xref>). The reduction in hair cells in the lateral line labeled with FM1-43X indicates the failure of hair cells to mature or to normally function under AG treatment.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>The zebrafish model of AG induced ototoxicity. <bold>(A–F</bold>, <bold>E–H)</bold> Reduced numbers of neuromast hair cells in AG treated fish labeled by FM1-43 FX at 2 or 4 dpf, respectively. The reduction in hair cells was statistically different in the control &amp; treated groups.</p>
</caption>
<graphic xlink:href="fphar-08-00854-g0001"></graphic>
</fig>
</sec>
<sec>
<title>DNA and mRNA sequencing of zebrafish samples</title>
<p>To identify mRNA editing sites, we first sequenced mRNA from the 2 dpf embryos of the AB zebrafish line. We sequenced RNA from a total of nine AG treatment and control groups. Then, we sequenced DNA from adult zebrafish that represented the parental generation of the embryos. A total of 367.49 million mRNA sequencing reads and 219.2 million DNA sequencing reads were obtained. An average of 40.8 million reads or 4.0 Gb of mRNA-Seq data were generated per mRNA sample with a read length of 100 bp (paired-ends) and expected insertion size of 200 bp. The alignment rate against the reference genome (see section Materials and Methods) ranged from 94.04% (sample Genta_50_rep2) to 95.78% (sample Genta_50_rep1), with average mapping rates of 95.06 and 94.83% for control and drug-treated samples, respectively (Supplementary Table <xref ref-type="supplementary-material" rid="SM2">1</xref>).</p>
</sec>
<sec>
<title>RNA editing calling in control and AG-treated samples</title>
<p>We identified an average of 6,973 edited RNA sites in gene body regions per RNA sample, with the number of edited sites ranging from 6,859 to 7,019. Exposure to 25 μM gentamycin resulted in hair cell loss similar to that of 50 μM gentamycin; therefore, we combined the data obtained from these samples in subsequent analyses. Finally, we identified 6,850 overlapping mRNA editing sites and calculated the level of editing in control, gentamycin, and neomycin-treated samples (Supplementary Table <xref ref-type="supplementary-material" rid="SM3">2</xref>). Of the edited sites, 5,662 consisted of canonical, A-to-G or T-to-C editing. Two types of transitions, G-to-A and C-to-T, accounted for 77.4% of the non-canonical events observed.</p>
<p>We verified a subset of the edited RNA sites using PCR amplification and Sanger sequencing of DNA and mRNA (reverse-transcribed to cDNA). We examined 182 editing sites across 17 genes, including 13 G-to-A and C-to-T editing events. The validation results yielded a false-discovery rate of 5.33% (9/169) for A-to-G or T-to-C sites identified in our analysis, which was lower than the false-discovery rate for canonical sites in the previous study (Peng et al., <xref ref-type="bibr" rid="B51">2012</xref>). The false-discovery rate for the non-canonical type was ~84.6% (11/13; Supplementary Table <xref ref-type="supplementary-material" rid="SM4">3</xref>). The validation of editing events in the <italic>sp4</italic> and <italic>si</italic>:<italic>ch211-114n24.7</italic> genes is shown as representative examples (Supplementary Image <xref ref-type="supplementary-material" rid="SM1">1</xref>).</p>
</sec>
<sec>
<title>Characterization of mRNA editing sites</title>
<p>We identified 6,850 mRNA editing sites distributed over 762 genes. About 80% of these sites were A-to-G substitutions. The master list of editing sites contains 5,590 exonic sites, 1,243 intronic sites, and 17 sites located in regions with conflicting database annotations. Among exonic sites, the UTRs, especially the 3′ UTR, contained the greatest percentage of both A-to-G and non-A-to-G variants. CDS regions contained a total of 479 edited sites, of which 35% led to amino acid changes. Furthermore, there were significantly more non-A-to-G sites than A-to-G sites in CDS regions (<italic>p</italic> &lt; 2.2 × 10<sup>−16</sup>). Among the 762 genes with editing sites identified in this study, 299 genes were reported to contain editing sites in previous studies of the human transcriptome (Peng et al., <xref ref-type="bibr" rid="B51">2012</xref>; Ramaswami et al., <xref ref-type="bibr" rid="B59">2013</xref>; Qiu et al., <xref ref-type="bibr" rid="B56">2016</xref>), 54 genes had been described as edited in the mouse transcriptome (Danecek et al., <xref ref-type="bibr" rid="B6">2012</xref>; Gu et al., <xref ref-type="bibr" rid="B16">2012</xref>), and 325 genes had been described as edited in the zebrafish transcriptome (Shamay-Ramot et al., <xref ref-type="bibr" rid="B68">2015</xref>). There were 279 genes which had not been described as edited before.</p>
<p>We also found that the RNA editing sites were clustered, with an average of nine editing sites per gene. The extent of A-to-G site clustering in our data set, with 60.06% of sites arranged in clusters of ≥3 sites within 100 bp, is lower than what is found in the DARNED database (85.02%) but is higher than that observed in another deep-sequencing data set acquired by Peng et al. (30.89%) (Kiran and Baranov, <xref ref-type="bibr" rid="B34">2010</xref>; Peng et al., <xref ref-type="bibr" rid="B51">2012</xref>). A large number of transcripts presented multiple editing sites (204 genes with ≥10 sites each), such as <italic>sp4, slc22a31, plekhm1, adrbk2, pkn1</italic>, and <italic>samhd1</italic>, which were validated with PCR and Sanger sequencing.</p>
<p>Pathway analysis of genes with mRNA editing sites in zebrafish was performed using PANTHER v.10 (Mi et al., <xref ref-type="bibr" rid="B44">2016</xref>). mRNA editing sites were significantly enriched (<italic>p</italic> &lt; 0.05) in the Huntington disease, semaphorin-mediated axon guidance, angiogenesis, pyrimidine metabolism, cytoskeletal regulation by Rho GTPase, and Alzheimer disease-presenilin and FGF signaling pathways (Supplementary Table <xref ref-type="supplementary-material" rid="SM5">4</xref>). Moreover, <italic>plch1</italic> and <italic>snap29</italic>, part of the 5HT2-type receptor-mediated signaling pathway, also contained several editing sites. These findings indicate that RNA editing participates in the maintenance and regulation of zebrafish development, and particularly in neural development.</p>
</sec>
<sec>
<title>Comparison of the degree of editing between AG-treated and control samples</title>
<p>RNA editing can affect anywhere from 0 to 100% of an RNA population and leads to a mixed RNA population. To explore the influence of AG on the mRNA editome, we investigated differences in the degree of editing between AG-treated and control samples (<bold>Figure 3A</bold>). Editing sites with more than a 15% change in the degree of editing in both AG treatments were included in the high variation group and used for further analysis. Notably, in the high variation group, 687 sites spanning 333 genes accounted for 43% of all detectable RNA-edited genes (Supplementary Table <xref ref-type="supplementary-material" rid="SM6">5</xref>). Of these RNA editing sites, 462 and 225 showed a lower and higher degree of editing, respectively, in AG-treated samples than in control samples. In the high variation group, canonical variants (A-to-G or T-to-C) accounted for 75.8% of all RNA edits. The average value of the editing degree variation was about 26% among down-regulated edits and 27% among up-regulated edits. A total of 21 editing events across 16 genes were likely to change the encoded amino acids, and 57% of these changes were non- canonical variants. Pathway analysis showed that the 333 genes in the high variation group were significantly enriched (<italic>p</italic> &lt; 0.05) in axon guidance mediated by netrin and in the FGF and Ras signaling pathways (Supplementary Table <xref ref-type="supplementary-material" rid="SM7">6</xref>).</p>
<p>A total of 178 genes with editing events were significantly enriched in lateral line cells or lateral line placode cells, with 76 genes containing editing events with editing variations of more than 15% between control and AG-treated samples (Jiang et al., <xref ref-type="bibr" rid="B27">2014</xref>; Steiner et al., <xref ref-type="bibr" rid="B72">2014</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>). Moreover, 24 editing sites were identified as having more than a 15% change in the level of editing following AG treatment in 12 genes potentially related to ototoxicity, including <italic>plekhm1, fgfr1a, sox9a</italic>, and <italic>calrl2</italic> (Karasawa et al., <xref ref-type="bibr" rid="B29">2011</xref>; Girotto et al., <xref ref-type="bibr" rid="B14">2013</xref>; Stamatiou and Stankovic, <xref ref-type="bibr" rid="B71">2013</xref>; Azaiez et al., <xref ref-type="bibr" rid="B3">2014</xref>; Table <xref ref-type="table" rid="T1">1</xref>). Editing events in the deafness-related genes <italic>bdp1</italic> and <italic>alms1</italic> led to amino acid changes, which may be one of the potential pathways of AG-induced ototoxicity. Other important genes with editing events with more than 15% variation that may change the amino acid sequence are listed in Table <xref ref-type="table" rid="T2">2</xref>. Furthermore, editing variation in the mitochondrial inner membrane-expressed gene <italic>oxa1l</italic> could also affect the biological function of the protein.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Venn-diagram highlighting percentage of genes with editing sites changed more than 15% in lateral line cell enriched genes. <bold>(A)</bold> One hundred and seventy-eight genes with editing events were significantly enriched in lateral line cells or lateral line placode cells, <bold>(B)</bold> 333 genes contained editing events with editing variations more than 15% between control and AG treatment samples.</p>
</caption>
<graphic xlink:href="fphar-08-00854-g0002"></graphic>
</fig>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Editing sites with more than 0.15 variation of editing level in genes associated with deafness and ototoxicity.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>ChromeChr</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Position</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Variation type</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Editing in control</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Editing in gentamycin</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Editing in neomycin</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Region</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Alteration</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene function</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr10</td>
<td align="center" colspan="1" rowspan="1" valign="top">2974831</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">38.9%</td>
<td align="center" colspan="1" rowspan="1" valign="top">66.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">67.6%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>marveld2a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr24</td>
<td align="center" colspan="1" rowspan="1" valign="top">40729176</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">66.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">90.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">97.9%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>tbc1d24</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr24</td>
<td align="center" colspan="1" rowspan="1" valign="top">40729155</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">66.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">45.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>tbc1d24</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr21</td>
<td align="center" colspan="1" rowspan="1" valign="top">9763713</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">67.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">42.2%</td>
<td align="center" colspan="1" rowspan="1" valign="top">50.6%</td>
<td align="left" colspan="1" rowspan="1" valign="top">CDS</td>
<td align="left" colspan="1" rowspan="1" valign="top">I/V</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>bdp1 (2 of 2)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr21</td>
<td align="center" colspan="1" rowspan="1" valign="top">9763719</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">68.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">44.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">50.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">CDS</td>
<td align="left" colspan="1" rowspan="1" valign="top">M/V</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>bdp1 (2 of 2)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5897211</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">60.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">62.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteopetrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5897300</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">32.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">59.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">59.6%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteopetrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5897334</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">58.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">79.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">100.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteopetrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5896131</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">46.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.3%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteopetrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5897541</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">65.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">30.5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteopetrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr20</td>
<td align="center" colspan="1" rowspan="1" valign="top">32527617</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">56.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.2%</td>
<td align="center" colspan="1" rowspan="1" valign="top">10.7%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ostm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteopetrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr1</td>
<td align="center" colspan="1" rowspan="1" valign="top">27553904</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">45%</td>
<td align="center" colspan="1" rowspan="1" valign="top">19.2%</td>
<td align="center" colspan="1" rowspan="1" valign="top">17.7%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ednrb1a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Waardenburg IV syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr10</td>
<td align="center" colspan="1" rowspan="1" valign="top">3459366</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">88.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">51.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">64.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ptpn11a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Leopard I syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr13</td>
<td align="center" colspan="1" rowspan="1" valign="top">8739101</td>
<td align="left" colspan="1" rowspan="1" valign="top">G-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">30.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">15.5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">CDS</td>
<td align="left" colspan="1" rowspan="1" valign="top">R/H</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>alms1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alstrom Syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr13</td>
<td align="center" colspan="1" rowspan="1" valign="top">31129396</td>
<td align="left" colspan="1" rowspan="1" valign="top">G-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">28.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">10.9%</td>
<td align="center" colspan="1" rowspan="1" valign="top">10.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">CDS</td>
<td align="left" colspan="1" rowspan="1" valign="top">K/K</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ercc6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cockayne type B syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr13</td>
<td align="center" colspan="1" rowspan="1" valign="top">46955730</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">77.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">52.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">60.6%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>fgfr2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Crouzon &amp; Apert syndromes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr8</td>
<td align="center" colspan="1" rowspan="1" valign="top">53710690</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">61.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">44.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">45.5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>fgfr1a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfeiffer syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr8</td>
<td align="center" colspan="1" rowspan="1" valign="top">53711300</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">69.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">28.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">45.7%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>fgfr1a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfeiffer syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr8</td>
<td align="center" colspan="1" rowspan="1" valign="top">53711318</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">31.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">12.2%</td>
<td align="center" colspan="1" rowspan="1" valign="top">9.4%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>fgfr1a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfeiffer syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr8</td>
<td align="center" colspan="1" rowspan="1" valign="top">53711323</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">30.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.2%</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>fgfr1a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfeiffer syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">2152293</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">71.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">28.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">53.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>sox9a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ear development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">2152698</td>
<td align="left" colspan="1" rowspan="1" valign="top">G-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">45.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">15.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">22.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>sox9a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ear development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr8</td>
<td align="center" colspan="1" rowspan="1" valign="top">17101817</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">91.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">64.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">69.4%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>calrl2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">AG binding</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr8</td>
<td align="center" colspan="1" rowspan="1" valign="top">17101934</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">74.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">46.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">37.7%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>calrl2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">AG binding</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Missense editing variants with more than 0.15 variation of editing level.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Chrome Chr</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Position</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Variation type</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Editing in control</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Editing in gentamycin</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Editing in neomycin</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Alteration</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene name</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr7</td>
<td align="center" colspan="1" rowspan="1" valign="top">20754724</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">29.8%</td>
<td align="left" colspan="1" rowspan="1" valign="top">K/R</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>oxa1l</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr21</td>
<td align="center" colspan="1" rowspan="1" valign="top">7195948</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">64.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">46.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">47.6%</td>
<td align="left" colspan="1" rowspan="1" valign="top">M/V</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>f2rl1.2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr21</td>
<td align="center" colspan="1" rowspan="1" valign="top">7196037</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">75.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">52.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">42.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">H/R</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>f2rl1.2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr21</td>
<td align="center" colspan="1" rowspan="1" valign="top">7196041</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">74.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">52.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/D</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>f2rl1.2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr7</td>
<td align="center" colspan="1" rowspan="1" valign="top">53947931</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">55.9%</td>
<td align="center" colspan="1" rowspan="1" valign="top">33.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">20.5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">K/E</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>cgnl1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr7</td>
<td align="center" colspan="1" rowspan="1" valign="top">53948123</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">54.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">35.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">30.9%</td>
<td align="left" colspan="1" rowspan="1" valign="top">S/G</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>cgnl1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr25</td>
<td align="center" colspan="1" rowspan="1" valign="top">32457360</td>
<td align="left" colspan="1" rowspan="1" valign="top">T-&gt;C</td>
<td align="center" colspan="1" rowspan="1" valign="top">59.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">43.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">32.6%</td>
<td align="left" colspan="1" rowspan="1" valign="top">C/R</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>rassf8l</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr21</td>
<td align="center" colspan="1" rowspan="1" valign="top">9413646</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">56.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">30.2%</td>
<td align="left" colspan="1" rowspan="1" valign="top">T/I</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>alpk2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr6</td>
<td align="center" colspan="1" rowspan="1" valign="top">29017626</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">38.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">22.9%</td>
<td align="center" colspan="1" rowspan="1" valign="top">16.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/T</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>bivm</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr15</td>
<td align="center" colspan="1" rowspan="1" valign="top">5724304</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">53.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">32.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">34.5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">R/Q</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>brwd1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr23</td>
<td align="center" colspan="1" rowspan="1" valign="top">17169862</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">49.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.9%</td>
<td align="center" colspan="1" rowspan="1" valign="top">13.6%</td>
<td align="left" colspan="1" rowspan="1" valign="top">S/L</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>dnmt3</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr25</td>
<td align="center" colspan="1" rowspan="1" valign="top">29250985</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">51.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">34.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">23.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Q/Stop</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ptprz1a</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr11</td>
<td align="center" colspan="1" rowspan="1" valign="top">38600377</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">57.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">32.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">23.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">T/I</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>zgc:113019</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr16</td>
<td align="center" colspan="1" rowspan="1" valign="top">18334447</td>
<td align="left" colspan="1" rowspan="1" valign="top">G-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">26.2%</td>
<td align="center" colspan="1" rowspan="1" valign="top">31.8%</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/T</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>setd2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr19</td>
<td align="center" colspan="1" rowspan="1" valign="top">539349</td>
<td align="left" colspan="1" rowspan="1" valign="top">G-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">50.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">34.9%</td>
<td align="center" colspan="1" rowspan="1" valign="top">30.8%</td>
<td align="left" colspan="1" rowspan="1" valign="top">E/K</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>akap9</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr2</td>
<td align="center" colspan="1" rowspan="1" valign="top">49607422</td>
<td align="left" colspan="1" rowspan="1" valign="top">G-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">38.9%</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">14.3%</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/S</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>abhd17aa</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr21</td>
<td align="center" colspan="1" rowspan="1" valign="top">9404526</td>
<td align="left" colspan="1" rowspan="1" valign="top">G-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">57.9%</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">23.3%</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/D</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>alpk2</italic>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Characteristics of RNA sequence context under the AG treatment</title>
<p>We wanted to investigate whether there were sequence characteristics underlying the AG targeting of RNA. Therefore, we compared the flanking sequences of editing sites with editing variations &gt;15% of control and AG-treated samples (high variation group) with those that had &lt;5% variation in the degree of editing (low variation group; Figure <xref ref-type="fig" rid="F3">3B</xref>). We found that sites in the high variation group were flanked by G-enriched sequences and exhibited a depletion of C nucleotides downstream of the edited site. This agrees with previous findings that the C nucleotide is underrepresented at the +1 position of editing sites in zebrafish, while G is overrepresented at the +1 position of editing sites in humans and mice (Shamay-Ramot et al., <xref ref-type="bibr" rid="B68">2015</xref>). This is also in agreement with the 3′ nearest neighbor preferences of the ADAR2 enzymes, with G being preferred (Eggington et al., <xref ref-type="bibr" rid="B10">2011</xref>). Additionally, the presence of a T nucleotide four bases downstream of the edited site was characteristic of sites with down-regulated degrees of editing (more than 15%) in AG-treated samples. Enrichment of G nucleotides three bases upstream of the edited site was characteristics of sites with up-regulated degrees of editing (more than 15%) in AG-treated samples (Figure <xref ref-type="fig" rid="F3">3C</xref>). Nucleotide preferences in the flanking sequences of RNA editing sites indicate that the binding of AG is facilitated by specific sequence and structural features.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Global biological properties of editome in control and drug treated samples. <bold>(A)</bold> Distribution and fluctuation of whole editome under AG treatment. Each spot represents one editing site, of which the X-axis shows the location on chromosome and Y-axis shows the change of editing degree. Spots are highlighted in colors as follows: from yellow to red, editing degree higher in AG treatment; from green to blue, editing degree higher in wide type, the degree of color deepening was related to the change of editing degree. <bold>(B)</bold> Two sample logo of the differences between editing sites in high variation and low variation groups under drug treatment for the <italic>p</italic>-value threshold of 0.05. <bold>(C)</bold> Two sample logo of the differences between editing sites with higher editing degree in drug treated orwith higher editing degree in control groups for the <italic>p</italic>-value threshold of 0.05.</p>
</caption>
<graphic xlink:href="fphar-08-00854-g0003"></graphic>
</fig>
</sec>
<sec>
<title>Comparison of gene expression in AG-treated and control samples</title>
<p>We measured variations in gene expression between the AG-treated and control 2 dpf embryo samples. RNA of all samples were isolated from whole embryos. The expression of 988 genes differed more than 1.5-fold between both neomycin and gentamycin-treated samples and normal control samples. Of these genes, 257 genes were lateral line-enriched genes identified in previous studies (Jiang et al., <xref ref-type="bibr" rid="B27">2014</xref>; Steiner et al., <xref ref-type="bibr" rid="B72">2014</xref>). Among the 722 genes with down-regulated expression in the two AG-treated samples (Supplementary Table <xref ref-type="supplementary-material" rid="SM8">7</xref>), 113 genes were also down-regulated more than 1.5-fold in the expression analysis of lateral line cells at 1 h after neomycin-induced hair cell death, including <italic>her6, etv4</italic>, and <italic>tcf7l1a</italic> (Jiang et al., <xref ref-type="bibr" rid="B27">2014</xref>). Twenty-seven of the down-regulated genes, including <italic>ptprq, ush1g, climp-63</italic>, and genes involved in the Wnt, Notch, and FGF signaling pathways, play important roles in ear development or ototoxicity (Karasawa et al., <xref ref-type="bibr" rid="B28">2010</xref>; Stamatiou and Stankovic, <xref ref-type="bibr" rid="B71">2013</xref>; Jiang et al., <xref ref-type="bibr" rid="B27">2014</xref>; Table <xref ref-type="table" rid="T3">3</xref>). There were 266 genes with up-regulated expression in AG-treated samples, among which 47 genes were up-regulated more than 1.5-fold in the lateral line cells at 1 h after neomycin-induced hair cell death (Jiang et al., <xref ref-type="bibr" rid="B27">2014</xref>). Pathway analysis showed that down-regulated genes were significantly enriched (<italic>p</italic> &lt; 0.05) in cytoskeletal regulation by Rho GTPase and the thyrotropin-releasing hormone receptor, cadherin, and Wnt signaling pathways (Supplementary Table <xref ref-type="supplementary-material" rid="SM9">8</xref>). Up-regulated genes were significantly enriched (<italic>p</italic> &lt; 0.05) in DNA replication and in the apoptosis signaling pathway (Supplementary Table <xref ref-type="supplementary-material" rid="SM10">9</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Deafness and ototoxicity genes were down-regulated more than 1.5 fold change in AG treated Zebrafish.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene name</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Control (FPKM)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Gentamycin (FPKM)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Log (fold)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Neomycin (FPKM)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Log (fold)</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene related phenotype or function</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ush1g</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.44</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.10</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−2.10</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.24</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.86</td>
<td align="left" colspan="1" rowspan="1" valign="top">Syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>pcdh15b</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">1.51</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.51</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.58</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.39</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.96</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ptprq</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.49</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.07</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−2.78</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.12</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−2.02</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>col1a1a</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">1001.63</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">626.27</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.68</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">466.45</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteogenesis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>twist1a</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">40.15</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">24.23</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.73</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">24.84</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.69</td>
<td align="left" colspan="1" rowspan="1" valign="top">Syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>diabloa</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">17.56</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">9.13</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.94</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">8.42</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.06</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>actb2</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">4882.95</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">2675.42</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.87</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">2703.10</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.85</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deafness (animal experiment)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>tyr</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">55.70</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">33.88</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.72</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">22.99</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.28</td>
<td align="left" colspan="1" rowspan="1" valign="top">Syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>lrtomt</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.63</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.31</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.01</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.36</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.81</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>fetub</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">1040.03</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">650.12</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.68</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">369.93</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.49</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deafness (animal experiment)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">4.75</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">3.12</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.60</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">2.98</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.67</td>
<td align="left" colspan="1" rowspan="1" valign="top">Osteopetrosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>fgf10b</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.44</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.18</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.30</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.22</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.01</td>
<td align="left" colspan="1" rowspan="1" valign="top">Syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>edn3</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">1.84</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.02</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−6.53</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.97</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.93</td>
<td align="left" colspan="1" rowspan="1" valign="top">Syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>kctd1</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">2.32</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.93</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.32</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">1.46</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.67</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deafness (animal experiment)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>apoa1b</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">5865.83</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">3853.52</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.61</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">3544.56</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.73</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deafness (animal experiment)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>cldn2</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">1.05</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.58</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.84</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.57</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.88</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non syndromic hearing loss</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>dachc</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">6.26</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">4.07</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.62</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">3.68</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.77</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ear development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>fgf5</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.74</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.27</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.46</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.22</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.76</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ear development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>fgf20b</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">1.21</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.68</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.84</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">0.66</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.87</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ear development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>etv4</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">25.05</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">14.80</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.76</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">12.94</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.95</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ear development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>snai1b</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">4.79</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">2.98</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.69</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">2.95</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.70</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ear development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>her6</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">60.58</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">37.20</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.70</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">34.28</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.82</td>
<td align="left" colspan="1" rowspan="1" valign="top">Notch signaling pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>her12</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">116.63</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">62.82</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.89</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">65.52</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.83</td>
<td align="left" colspan="1" rowspan="1" valign="top">Notch signaling pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>tcf7l1a</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">37.23</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">24.73</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.59</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">18.14</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.04</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wnt signaling pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>jun</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">97.64</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">60.41</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.69</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">36.52</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.42</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wnt signaling pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>sfrp1b</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">19.61</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">9.56</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.04</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">7.53</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−1.38</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wnt signaling pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>climp-63</italic>
</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">143.45</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">86.49</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.73</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">72.02</td>
<td align="char" char="." colspan="1" rowspan="1" valign="top">−0.99</td>
<td align="left" colspan="1" rowspan="1" valign="top">AG binding</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Relationship between editing and gene expression</title>
<p>The RNA-seq data allowed us to assess the connection between RNA editing and gene expression in the experimental samples. Increases in the level of RNA editing were weakly, but significantly, correlated with increases in gene expression in the gentamycin treatment group (Pearson's correlation test: <italic>r</italic> = 0.10, 95% CI: 0.06–0.20, <italic>p</italic> = 0.0088; Figure <xref ref-type="fig" rid="F4">4</xref>). Moreover, 160 editing sites were located in 19 genes with more than a 1.5-fold difference in expression between AG-treated and control samples. The degree of editing changed more than 15% in 21 of these editing sites, and all but two were located in non-coding regions (Table <xref ref-type="table" rid="T4">4</xref>). Among these 21 editing sites, three were predicted by MIRANDA to alter or create miRNA binding sites and possibly affect the expression of <italic>shmt2, si:ch211-241b2.1</italic>, and <italic>plekhm1</italic> (Table <xref ref-type="table" rid="T5">5</xref>). Under AG treatment, the expression levels of <italic>shmt2</italic> and <italic>plekhm1</italic> were down-regulated more than 1.5-fold with the up-regulated editing of these two miRNA binding sites. <italic>shmt2</italic> (serine hydroxymethyltransferase 2) is mainly distributed in the mitochondria and plays an important role in mitochondrial DNA synthesis and glycine production, while <italic>plekhm1</italic> is associated with syndromic hearing loss (Van Wesenbeeck et al., <xref ref-type="bibr" rid="B78">2007</xref>; Anderson and Stover, <xref ref-type="bibr" rid="B2">2009</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Relationship between editing level and expression change. Correlation between editing level and mRNA level changes of associated genes between gentamycin treated and control groups (Pearson's correlation test: <italic>r</italic> = 0.10, 95% CI: 0.06–0.20, <italic>p</italic> = 0.0088). Each red dot stood for an editing site with a cutoff of 15% editing level change.</p>
</caption>
<graphic xlink:href="fphar-08-00854-g0004"></graphic>
</fig>
<table-wrap id="T4" position="float">
<label>Table 4</label>
<caption>
<p>Genes changed more than 1.5 fold change in expression and more than 15% in editing degree.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Genome Chr</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Position</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Variation Type</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Editing in Control</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Editing in Gentamycin</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Editing in Neomycin</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Region/Alteration</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Expression change</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr1</td>
<td align="center" colspan="1" rowspan="1" valign="top">37502</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">19.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">43.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">37.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>f10</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5897211</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">60.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">62.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5897300</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">32.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">59.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">59.6%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5897334</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">58.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">79.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">100.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr19</td>
<td align="center" colspan="1" rowspan="1" valign="top">46815419</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">10.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">28.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">32.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>cu694368.1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr3</td>
<td align="center" colspan="1" rowspan="1" valign="top">55688757</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">16.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">32.2%</td>
<td align="center" colspan="1" rowspan="1" valign="top">32.3%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ubald1b</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr6</td>
<td align="center" colspan="1" rowspan="1" valign="top">59149763</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">40.5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>shmt2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr7</td>
<td align="center" colspan="1" rowspan="1" valign="top">20754724</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">29.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.7%</td>
<td align="left" colspan="1" rowspan="1" valign="top">CDS</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>oxa1l</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr16</td>
<td align="center" colspan="1" rowspan="1" valign="top">35895953</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">36.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">81.6%</td>
<td align="center" colspan="1" rowspan="1" valign="top">71.9%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>si:dkey-248g17.3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5896131</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">46.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.3%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5897541</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">65.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">30.5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">26797012</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">91.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">72.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">76.4%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>mta3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">26797182</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">28.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">12.9%</td>
<td align="center" colspan="1" rowspan="1" valign="top">10.6%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>mta3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">26797214</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">70.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">53.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">37.5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>mta3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">26797227</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">32.1%</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">14.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>mta3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr19</td>
<td align="center" colspan="1" rowspan="1" valign="top">46815518</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">59.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">18.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">43.8%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>cu694368.1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr20</td>
<td align="center" colspan="1" rowspan="1" valign="top">36940734</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;T</td>
<td align="center" colspan="1" rowspan="1" valign="top">73.2%</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">45.1%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>cited2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr3</td>
<td align="center" colspan="1" rowspan="1" valign="top">55687706</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">51.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">30.7%</td>
<td align="center" colspan="1" rowspan="1" valign="top">36.2%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ubald1b</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr3</td>
<td align="center" colspan="1" rowspan="1" valign="top">55687778</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">33.2%</td>
<td align="center" colspan="1" rowspan="1" valign="top">16.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">10.8%</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ubald1b</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr15</td>
<td align="center" colspan="1" rowspan="1" valign="top">826092</td>
<td align="left" colspan="1" rowspan="1" valign="top">C-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">63.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">22.0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">18.8%</td>
<td align="left" colspan="1" rowspan="1" valign="top">CDS</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>si:dkey-7i4.7</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr21</td>
<td align="center" colspan="1" rowspan="1" valign="top">2596180</td>
<td align="left" colspan="1" rowspan="1" valign="top">G-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">54.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">14.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">26.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>si:ch211-241b2.1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up-regulated</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T5" position="float">
<label>Table 5</label>
<caption>
<p>Genes with editing sites in potential miRNA binding elements changed more than 15% in editing degree and 1.5-fold in expression.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Genome</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Variation Type</bold>
</th>
<th align="center" colspan="3" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Editing degree in different treatment</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>miRNA binding in editing sites</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Expression Change ≥1.5 fold change</bold>
</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Chr</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Position</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Control</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Genta</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Neo</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Before editing</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>After editing</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr12</td>
<td align="center" colspan="1" rowspan="1" valign="top">5897334</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">58.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">79.4%</td>
<td align="center" colspan="1" rowspan="1" valign="top">100.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">dre-miR-726: G|C</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>plekhm1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr21</td>
<td align="center" colspan="1" rowspan="1" valign="top">2596180</td>
<td align="left" colspan="1" rowspan="1" valign="top">G-&gt;A</td>
<td align="center" colspan="1" rowspan="1" valign="top">54.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">14.3%</td>
<td align="center" colspan="1" rowspan="1" valign="top">26.0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">dre-miR-735-3p: G|C</td>
<td align="left" colspan="1" rowspan="1" valign="top">dre-miR-26a-2-3p: A|U</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>si:ch211-241b2.1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">chr6</td>
<td align="center" colspan="1" rowspan="1" valign="top">59149763</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-&gt;G</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.8%</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.5%</td>
<td align="center" colspan="1" rowspan="1" valign="top">40.5%</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">dre-miR-727-5p: G|C</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>shmt2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulated</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>RNA editing is an essential gene regulatory mechanism and is quite prevalent throughout the transcriptome. Deficiencies in ADAR can lead to lethality or severe defects of the nervous system in flies, zebrafish, and mice (Palladino et al., <xref ref-type="bibr" rid="B50">2000</xref>; Horsch et al., <xref ref-type="bibr" rid="B24">2011</xref>; Li et al., <xref ref-type="bibr" rid="B40">2014</xref>). In humans, the deregulation of RNA editing is associated with some types of cancer and several neurological diseases (Eran et al., <xref ref-type="bibr" rid="B12">2013</xref>; Gallo et al., <xref ref-type="bibr" rid="B13">2017</xref>). The dynamic regulation of RNA editing in the human brain was found to be associated with neuronal maturation, while hyper-editing was selectively perturbed in spinal cord injury and glioblastoma (Hwang et al., <xref ref-type="bibr" rid="B25">2016</xref>). There is increasing evidence to support that RNA editing is one of molecular mechanisms connecting environmental stimuli and phenotypic or behavioral output.</p>
<p>With the aid of high-throughput RNA sequencing technologies, more and more RNA editing sites have been identified in humans (<italic>Homo sapiens</italic>; Ramaswami et al., <xref ref-type="bibr" rid="B59">2013</xref>), mice (<italic>Mus musculus</italic>; Danecek et al.), and flies (<italic>Drosophila melanogaster</italic>; St Laurent et al., <xref ref-type="bibr" rid="B75">2013</xref>). Previous study by Ramaswami et al. identified 370,623 RNA editing sites in the human transcriptome, while a study by Danecek et al. found 7,389 editing sites in the mouse brain (Danecek et al., <xref ref-type="bibr" rid="B6">2012</xref>; Ramaswami et al., <xref ref-type="bibr" rid="B59">2013</xref>). Additionally, among 1,745 genes contained editing sites in mice, 1,206 genes were also reported to contain editing sites in humans (Gu et al., <xref ref-type="bibr" rid="B16">2012</xref>). A recent study identified ~350,000 DNA–RNA mismatches using a dataset that contained 17 zebrafish samples covering eight different developmental stages (Shamay-Ramot et al., <xref ref-type="bibr" rid="B68">2015</xref>). RNA-seq data have been analyzed using a bioinformatics pipeline masking adenosine (A) sites with guanine (G) to find extensive hyperedited RNA sites (Porath et al., <xref ref-type="bibr" rid="B54">2014</xref>). Here, 6,850 mRNA editing events in embryonic zebrafish at 2 dpf were identified by next-generation sequencing technologies and the recently published SPRINT method (Zhang et al., <xref ref-type="bibr" rid="B87">2017</xref>). We found that 74% of all editing sites were located in the 3′ UTR regions of genes. It will be an exciting challenge to uncover the roles of these editing sites in biology and disease in future studies.</p>
<p>AG have been used to treat serious or recalcitrant gram-negative infections for more than 70 years (Schatz and Waksman, <xref ref-type="bibr" rid="B64">1944</xref>). However, the clinical utility of these antibiotics is limited because they induce nephrotoxicity and ototoxicity (Rizzi and Hirose, <xref ref-type="bibr" rid="B60">2007</xref>). AG-induced ototoxicity is associated with several human mitochondria variants. Individuals who carry 1555A-G or 1494C-T mutations in the mitochondrial 12S rRNA gene are susceptible to AG-induced ototoxicity, as these transitions make human mitochondrial ribosomes more “bacteria-like” for AG binding (Guan, <xref ref-type="bibr" rid="B17">2011</xref>). Moreover, people who do not carry mutations in the 12S rRNA gene also suffer from AG-induced hearing loss, indicating a more complex mechanism of AG-induced ototoxicity.</p>
<p>After systemic administration of AG, damage occurs to the sensory hair cells, which is innervated by neurons of the statoacoustic ganglion (SAG; Sone et al., <xref ref-type="bibr" rid="B70">1998</xref>). The inhibition of mitochondrial protein synthesis and induction of mitochondrial dysfunction may be ways that AG exert toxicity when accumulating in hair cells (Dehne et al., <xref ref-type="bibr" rid="B7">2002</xref>). AG also initiate multiple pathways, including the formation of reactive oxygen species (Rybak and Ramkumar, <xref ref-type="bibr" rid="B61">2007</xref>), the activation of the c-Jun N-terminal kinase pathway, and caspase-dependent or -independent signals (Jiang et al., <xref ref-type="bibr" rid="B26">2006</xref>), leading to necrotic or apoptotic cell death.</p>
<p>Clinically, AG-induced hearing loss is one of the main causes of drug-induced deafness in children which could be partly due to newborns and infants are more susceptible to drug-induced ototoxicity than adults (Scaglione et al., <xref ref-type="bibr" rid="B63">1995</xref>; Li et al., <xref ref-type="bibr" rid="B41">2005</xref>). Embryonic zebrafish as a model to carry out the ototoxic effects of AG may effectively increase awareness of AG-ototoxic pathogenic mechanism in young children.</p>
<p>The present study assessed the dynamic variation of the editome after exposure to AG. The high variations of editing in <italic>plekhm1, sox9a, fgfr1a</italic>, and <italic>fgfr2</italic> observed under AG treatment indicated potential effects of AG on inner ear development. Each of these genes is involved in some aspect of inner ear development. <italic>plekhm1</italic> plays an important role in the development and formation of the otic capsule (Van Wesenbeeck et al., <xref ref-type="bibr" rid="B78">2007</xref>). <italic>sox9a</italic> is a target of the FGF3 and FGF8 signaling pathways (Nicolson, <xref ref-type="bibr" rid="B46">2005</xref>). <italic>fgfr1a</italic> is prominently expressed in neuromasts of the posterior lateral line and is important in the generation of the precursor pool that grows into the auditory sensory epithelium (Pirvola et al., <xref ref-type="bibr" rid="B53">2002</xref>). <italic>fgfr2</italic>, a cognate receptor of <italic>fgf3</italic> and <italic>fgf10</italic>, is expressed in the otocyst nonsensory epithelium and regulates inner ear morphogenesis (Pirvola et al., <xref ref-type="bibr" rid="B52">2000</xref>). Notably, <italic>calrl2</italic>, which encodes a protein that binds to gentamicin to reduce drug-induced ototoxicity, contains three editing sites in the 3′ UTR, among which the editing level of two sites was largely down-regulated under AG treatment (Karasawa et al., <xref ref-type="bibr" rid="B29">2011</xref>). Thus, for the first time, we have demonstrated that AG have a significant effect on the biological properties of mRNA editing sites. This finding provides new insight into the mechanisms of AG-induced ototoxicity. The mechanism of AG induced editing variation may be that AG bind to specific internal loop motif to affect the formation of dsRNA that are edited by ADAR (Lehmann and Bass, <xref ref-type="bibr" rid="B36">1999</xref>; Disney et al., <xref ref-type="bibr" rid="B8">2008</xref>), AG may affect the affinity of ADAR and substrate RNA, and then result in the change of editing efficiency.</p>
<p>Expression profile analysis also showed that the expression of some members, or targets, of the FGF signaling pathway were down-regulated more than 1.5-fold under AG treatment (Raible and Brand, <xref ref-type="bibr" rid="B58">2001</xref>). The FGF signaling pathway regulates the developmental processes of the inner ear, including the ontogeny of the SAG and hair cells in zebrafish (Wang et al., <xref ref-type="bibr" rid="B82">2015</xref>). <italic>fgf5</italic>, expressed in mature SAG neurons (Vemaraju et al., <xref ref-type="bibr" rid="B79">2012</xref>) and some other cranial ganglia from 24 to 48 hpf, was the most down-regulated gene in this pathway. <italic>fgf5</italic> plays a major role in slowing the rate of maturation of new SAG neurons and in expanding the size of the progenitor cell pool for future use. Taken together, the depletion of <italic>fgf5</italic> after AG treatment would be expected to promote the maturation of neurons and advance the deletion of progenitors, leading to an overall SAG deficiency.</p>
<p>Moreover, the expression of some hearing loss-related genes was down regulated after treatment with AG, with <italic>ptprq</italic> expression decreasing the most. <italic>Ptprq</italic> encodes the cytoplasmic protein tyrosine phosphatase receptor Q, which has activity against phosphatidylinositol phosphates (Wright et al., <xref ref-type="bibr" rid="B86">1998</xref>). Protein tyrosine phosphatase receptor Q regulates the local phosphoinositide phospholipid content of the hair cell apical membrane (Oganesian et al., <xref ref-type="bibr" rid="B48">2003</xref>) and participates in the normal maturation of developing cochlear hair bundles (Goodyear et al., <xref ref-type="bibr" rid="B15">2003</xref>). AG bind to free phosphoinositides, which regulate KCNQ4 channel activity, leading to the inhibition of the potassium efflux necessary for the survival and function of cochlear sensory hair cells (Leitner et al., <xref ref-type="bibr" rid="B37">2011</xref>). The down-regulation of phosphoinositide in the specific sensory tissue by <italic>ptprq</italic> is likely to be responsible for the selective susceptibility of inner ear hair cells to AG.</p>
<p>Meanwhile, genes with more than 1.5-fold down-regulated expression in AG-treated samples were enriched in the Wnt and cadherin signaling pathways. Wnt signaling is required for proliferation in developing neuromasts, and there are intriguing connections between the Wnt and cadherin signaling pathways in AG-induced ototoxicity (Nelson and Nusse, <xref ref-type="bibr" rid="B45">2004</xref>; Head et al., <xref ref-type="bibr" rid="B21">2013</xref>). As one of genes in the Wnt signaling pathway, <italic>tcf7l1a</italic> is a conserved transcription factor whose function as a transcriptional repressor is necessary for early nervous system development in zebrafish (Dorsky et al., <xref ref-type="bibr" rid="B9">2003</xref>). The down-regulated expression of <italic>tcf7l1a</italic> was also reported after treatment with neomycin in a previous study (Jiang et al., <xref ref-type="bibr" rid="B27">2014</xref>).</p>
<p>In addition, two mitochondria-related genes, <italic>oxa1l</italic> and <italic>shmt2</italic>, showed changes in both editing degree and expression after exposure to AG. The <italic>oxa1l</italic> gene encodes an evolutionarily conserved mitochondrial inner membrane protein, the C-terminal tail of which binds mitochondrial ribosomes, coordinating the synthesis and membrane insertion of the nascent chains into the membrane (Haque et al., <xref ref-type="bibr" rid="B19">2010</xref>). Knocking out this gene in HEK293 cells leads to a significant decrease in the steady-state level and activity of mitochondrial F (1) F (o)-ATP synthase (Stiburek et al., <xref ref-type="bibr" rid="B74">2007</xref>). Moreover, the editing sites of <italic>shmt2</italic> were all located in the 3′ UTR region, and the editing degree variation in one of these sites may influence its binding with an miRNA under AG treatment. <italic>shmt2</italic> plays an important role in the synthesis of mitochondrial glycine for mitochondrial DNA generation. The down-regulation of <italic>shmt2</italic> expression in HeLa cells affects the integrity of the mitochondrial DNA content and in elderly human fibroblast lines regulates glycine production in the mitochondria, resulting in respiration defects (Anderson and Stover, <xref ref-type="bibr" rid="B2">2009</xref>; Hashizume et al., <xref ref-type="bibr" rid="B20">2015</xref>).</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusion</title>
<p>Taken together, AG may widely influence the editome and expression profiles of genes, and these changes are potentially correlated with AG-induced ototoxicity. These results provide new insight into the ototoxic mechanism of AG. However, the interactions between AG, RNA editing, and hearing loss involve complex processes, and additional studies are required to fully elucidate the mechanisms involved. A better understanding of post-transcriptional editing events may not only help to improve our understanding of the pathogenesis of AG ototoxicity but also lead to the design of novel strategies for disease treatment.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>SY, YL, LH, and QX: designed and supervised the project; SY, HZ, MJ, and YS: performed the experiments; SY, YL, WT, and LW: analyzed the data; SY, YL and XZ: wrote the manuscript. All authors read and approved the final manuscript. All authors contributed to the interpretation of data, and revised the manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>We are thankful to Prof. Gang Peng and his team for technical support with zebrafish.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the National Natural Science Foundation of China (grants 31371274, 31611130035, and 81171992), the 973 Projects (2011CB710801) and the Shanghai Municipal Commission of Science and Technology Program (14DJ1400101). Scientific and Technological Research in Open Collaborative Projects of Henan Province (152106000044).</p>
</fn>
</fn-group>
<sec id="s7" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2017.00854/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2017.00854/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<label>Supplementary Image 1</label>
<caption>
<p>Validation of inferred editing sites from RNA-Seq by Sanger sequencing. Sequencing chromatogram traces from gene loci <italic>SP4</italic> and <italic>Si: ch211-114n24.7</italic>are shown. The editing positions (located in the 3′UTR of <italic>SP4</italic> and 5′ UTR of <italic>Si: ch211-114n24.7</italic>) are highlighted by yellow shading. Note the clustering of editing sites in the <italic>SP4</italic> transcript. Top trace is genomic DNA (gDNA), bottom trace cDNA.</p>
</caption>
<media xlink:href="Image1.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM2">
<media xlink:href="Table1.XLS">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM3">
<media xlink:href="Table2.XLS">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM4">
<media xlink:href="Table3.XLS">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM5">
<media xlink:href="Table4.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM6">
<media xlink:href="Table5.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM7">
<media xlink:href="Table6.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM8">
<media xlink:href="Table7.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM9">
<media xlink:href="Table8.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM10">
<media xlink:href="Table9.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM11">
<media xlink:href="Table10.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbarian</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name><name><surname>Jones</surname><given-names>E. G.</given-names></name></person-group> (<year>1995</year>). <article-title>Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia</article-title>. <source/>Brain Res.
<volume>699</volume>, <fpage>297</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(95)00922-D</pub-id><pub-id pub-id-type="pmid">8616634</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>D. D.</given-names></name><name><surname>Stover</surname><given-names>P. J.</given-names></name></person-group> (<year>2009</year>). <article-title>SHMT1 and SHMT2 are functionally redundant in nuclear <italic>de novo</italic> thymidylate biosynthesis</article-title>. <source/>PLoS ONE
<volume>4</volume>:<fpage>e5839</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0005839</pub-id><pub-id pub-id-type="pmid">19513116</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azaiez</surname><given-names>H.</given-names></name><name><surname>Booth</surname><given-names>K. T.</given-names></name><name><surname>Bu</surname><given-names>F.</given-names></name><name><surname>Huygen</surname><given-names>P.</given-names></name><name><surname>Shibata</surname><given-names>S. B.</given-names></name><name><surname>Shearer</surname><given-names>A. E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>TBC1D24 mutation causes autosomal-dominant nonsyndromic hearing loss</article-title>. <source/>Hum. Mutat.
<volume>35</volume>, <fpage>819</fpage>–<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22557</pub-id><pub-id pub-id-type="pmid">24729539</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>C. H.</given-names></name><name><surname>Chan</surname><given-names>T. H. M.</given-names></name><name><surname>Chow</surname><given-names>R. K. K.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma</article-title>. <source/>Nat. Med.
<volume>19</volume>, <fpage>209</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3043</pub-id><pub-id pub-id-type="pmid">23291631</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffin</surname><given-names>A. B.</given-names></name><name><surname>Reinhart</surname><given-names>K. E.</given-names></name><name><surname>Owens</surname><given-names>K. N.</given-names></name><name><surname>Raible</surname><given-names>D. W.</given-names></name><name><surname>Rubel</surname><given-names>E. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Extracellular divalent cations modulate aminoglycoside-induced hair cell death in the zebrafish lateral line</article-title>. <source/>Hear. Res.
<volume>253</volume>, <fpage>42</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.heares.2009.03.004</pub-id><pub-id pub-id-type="pmid">19285547</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P.</given-names></name><name><surname>Nellåker</surname><given-names>C.</given-names></name><name><surname>McIntyre</surname><given-names>R. E.</given-names></name><name><surname>Buendia-Buendia</surname><given-names>J. E.</given-names></name><name><surname>Bumpstead</surname><given-names>S.</given-names></name><name><surname>Ponting</surname><given-names>C. P.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>High levels of RNA-editing site conservation amongst 15 laboratory mouse strains</article-title>. <source/>Genome Biol.
<volume>13</volume>:<fpage>r26</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2012-13-4-r26</pub-id><pub-id pub-id-type="pmid">22524474</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehne</surname><given-names>N.</given-names></name><name><surname>Rauen</surname><given-names>U.</given-names></name><name><surname>de Groot</surname><given-names>H.</given-names></name><name><surname>Lautermann</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Involvement of the mitochondrial permeability transition in gentamicin ototoxicity</article-title>. <source/>Hear. Res.
<volume>169</volume>, <fpage>47</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-5955(02)00338-6</pub-id><pub-id pub-id-type="pmid">12121739</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Disney</surname><given-names>M. D.</given-names></name><name><surname>Labuda</surname><given-names>L. P.</given-names></name><name><surname>Paul</surname><given-names>D. J.</given-names></name><name><surname>Poplawski</surname><given-names>S. G.</given-names></name><name><surname>Pushechnikov</surname><given-names>A.</given-names></name><name><surname>Tran</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners</article-title>. <source/>J. Am. Chem. Soc.
<volume>130</volume>, <fpage>11185</fpage>–<lpage>11194</lpage>. <pub-id pub-id-type="doi">10.1021/ja803234t</pub-id><pub-id pub-id-type="pmid">18652457</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorsky</surname><given-names>R. I.</given-names></name><name><surname>Itoh</surname><given-names>M.</given-names></name><name><surname>Moon</surname><given-names>R. T.</given-names></name><name><surname>Chitnis</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Two tcf3 genes cooperate to pattern the zebrafish brain</article-title>. <source/>Development
<volume>130</volume>, <fpage>1937</fpage>–<lpage>1947</lpage>. <pub-id pub-id-type="doi">10.1242/dev.00402</pub-id><pub-id pub-id-type="pmid">12642497</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggington</surname><given-names>J. M.</given-names></name><name><surname>Greene</surname><given-names>T.</given-names></name><name><surname>Bass</surname><given-names>B. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Predicting sites of ADAR editing in double-stranded RNA</article-title>. <source/>Nat. Commun.
<volume>2</volume>:<fpage>319</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms1324</pub-id><pub-id pub-id-type="pmid">21587236</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enright</surname><given-names>A. J.</given-names></name><name><surname>John</surname><given-names>B.</given-names></name><name><surname>Gaul</surname><given-names>U.</given-names></name><name><surname>Tuschl</surname><given-names>T.</given-names></name><name><surname>Sander</surname><given-names>C.</given-names></name><name><surname>Marks</surname><given-names>D. S.</given-names></name></person-group> (<year>2003</year>). <article-title>MicroRNA targets in Drosophila</article-title>. <source/>Genome Biol.
<volume>5</volume>:<fpage>R1</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2003-5-1-r1</pub-id><pub-id pub-id-type="pmid">14709173</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eran</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>J. B.</given-names></name><name><surname>Vatalaro</surname><given-names>K.</given-names></name><name><surname>McCarthy</surname><given-names>J.</given-names></name><name><surname>Rahimov</surname><given-names>F.</given-names></name><name><surname>Collins</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Comparative RNA editing in autistic and neurotypical cerebella</article-title>. <source/>Mol. Psychiatry
<volume>18</volume>, <fpage>1041</fpage>–<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.118</pub-id><pub-id pub-id-type="pmid">22869036</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>A.</given-names></name><name><surname>Vukic</surname><given-names>D.</given-names></name><name><surname>Michalík</surname><given-names>D.</given-names></name><name><surname>O'Connell</surname><given-names>M. A.</given-names></name><name><surname>Keegan</surname><given-names>L. P.</given-names></name></person-group> (<year>2017</year>). <article-title>ADAR RNA editing in human disease; more to it than meets the I</article-title>. <source/>Hum. Genet.
<volume>136</volume>, <fpage>1265</fpage>–<lpage>1278</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-017-1837-0</pub-id><pub-id pub-id-type="pmid">28913566</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girotto</surname><given-names>G.</given-names></name><name><surname>Abdulhadi</surname><given-names>K.</given-names></name><name><surname>Buniello</surname><given-names>A.</given-names></name><name><surname>Vozzi</surname><given-names>D.</given-names></name><name><surname>Licastro</surname><given-names>D.</given-names></name><name><surname>d'Eustacchio</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Linkage study and exome sequencing identify a BDP1 mutation associated with hereditary hearing loss</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e80323</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0080323</pub-id><pub-id pub-id-type="pmid">24312468</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodyear</surname><given-names>R. J.</given-names></name><name><surname>Legan</surname><given-names>P. K.</given-names></name><name><surname>Wright</surname><given-names>M. B.</given-names></name><name><surname>Marcotti</surname><given-names>W.</given-names></name><name><surname>Oganesian</surname><given-names>A.</given-names></name><name><surname>Coats</surname><given-names>S. A.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>A receptor-like inositol lipid phosphatase is required for the maturation of developing cochlear hair bundles</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>9208</fpage>–<lpage>9219</lpage>. <pub-id pub-id-type="pmid">14534255</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>T.</given-names></name><name><surname>Buaas</surname><given-names>F. W.</given-names></name><name><surname>Simons</surname><given-names>A. K.</given-names></name><name><surname>Ackert-Bicknell</surname><given-names>C. L.</given-names></name><name><surname>Braun</surname><given-names>R. E.</given-names></name><name><surname>Hibbs</surname><given-names>M. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Canonical A-to-I and C-to-U RNA editing is enriched at 3'UTRs and microRNA target sites in multiple mouse tissues</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e33720</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033720</pub-id><pub-id pub-id-type="pmid">22448268</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>M.-X.</given-names></name></person-group> (<year>2011</year>). <article-title>Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity</article-title>. <source/>Mitochondrion
<volume>11</volume>, <fpage>237</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2010.10.006</pub-id><pub-id pub-id-type="pmid">21047563</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddon</surname><given-names>C.</given-names></name><name><surname>Lewis</surname><given-names>J.</given-names></name></person-group> (<year>1996</year>). <article-title>Early ear development in the embryo of the zebrafish, <italic>Danio rerio</italic></article-title>. <source/>J. Comp. Neurol.
<volume>365</volume>, <fpage>113</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19960129)365:1&lt;113::AID-CNE9&gt;3.0.CO;2-6</pub-id><pub-id pub-id-type="pmid">8821445</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname><given-names>M. E.</given-names></name><name><surname>Spremulli</surname><given-names>L. L.</given-names></name><name><surname>Fecko</surname><given-names>C. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Identification of protein-protein and protein-ribosome interacting regions of the C-terminal tail of human mitochondrial inner membrane protein Oxa1L</article-title>. <source/>J. Biol. Chem.
<volume>285</volume>, <fpage>34991</fpage>–<lpage>34998</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.163808</pub-id><pub-id pub-id-type="pmid">20739282</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashizume</surname><given-names>O.</given-names></name><name><surname>Ohnishi</surname><given-names>S.</given-names></name><name><surname>Mito</surname><given-names>T.</given-names></name><name><surname>Shimizu</surname><given-names>A.</given-names></name><name><surname>Ishikawa</surname><given-names>K.</given-names></name><name><surname>Nakada</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Epigenetic regulation of the nuclear-coded GCAT and SHMT2 genes confers human age-associated mitochondrial respiration defects</article-title>. <source/>Sci. Rep.
<volume>5</volume>:<fpage>10434</fpage>
<pub-id pub-id-type="doi">10.1038/srep10434</pub-id><pub-id pub-id-type="pmid">26000717</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Head</surname><given-names>J. R.</given-names></name><name><surname>Gacioch</surname><given-names>L.</given-names></name><name><surname>Pennisi</surname><given-names>M.</given-names></name><name><surname>Meyers</surname><given-names>J. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Activation of canonical Wnt/β-catenin signaling stimulates proliferation in neuromasts in the zebrafish posterior lateral line</article-title>. <source/>Dev. Dyn.
<volume>242</volume>, <fpage>832</fpage>–<lpage>846</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.23973</pub-id><pub-id pub-id-type="pmid">23606225</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendrix</surname><given-names>M.</given-names></name><name><surname>Priestley</surname><given-names>E. S.</given-names></name><name><surname>Joyce</surname><given-names>G. F.</given-names></name><name><surname>Wong</surname><given-names>C. H.</given-names></name></person-group> (<year>1997</year>). <article-title>Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance</article-title>. <source/>J. Am. Chem. Soc.
<volume>119</volume>, <fpage>3641</fpage>–<lpage>3648</lpage>. <pub-id pub-id-type="doi">10.1021/ja964290o</pub-id><pub-id pub-id-type="pmid">11540136</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermann</surname><given-names>T.</given-names></name><name><surname>Westhof</surname><given-names>E.</given-names></name></person-group> (<year>1999</year>). <article-title>Docking of cationic antibiotics to negatively charged pockets in RNA folds</article-title>. <source/>J. Med. Chem.
<volume>42</volume>, <fpage>1250</fpage>–<lpage>1261</lpage>. <pub-id pub-id-type="doi">10.1021/jm981108g</pub-id><pub-id pub-id-type="pmid">10197968</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horsch</surname><given-names>M.</given-names></name><name><surname>Seeburg</surname><given-names>P. H.</given-names></name><name><surname>Adler</surname><given-names>T.</given-names></name><name><surname>Aguilar-Pimentel</surname><given-names>J. A.</given-names></name><name><surname>Becker</surname><given-names>L.</given-names></name><name><surname>Calzada-Wack</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Requirement of the RNA-editing enzyme ADAR2 for normal physiology in mice</article-title>. <source/>J. Biol. Chem.
<volume>286</volume>, <fpage>18614</fpage>–<lpage>18622</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.200881</pub-id><pub-id pub-id-type="pmid">21467037</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>T.</given-names></name><name><surname>Park</surname><given-names>C.-K.</given-names></name><name><surname>Leung</surname><given-names>A. K. L.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Hyde</surname><given-names>T. M.</given-names></name><name><surname>Kleinman</surname><given-names>J. E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Dynamic regulation of RNA editing in human brain development and disease</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>1093</fpage>–<lpage>1099</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4337</pub-id><pub-id pub-id-type="pmid">27348216</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Sha</surname><given-names>S. H.</given-names></name><name><surname>Forge</surname><given-names>A.</given-names></name><name><surname>Schacht</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Caspase-independent pathways of hair cell death induced by kanamycin <italic>in vivo</italic></article-title>. <source/>Cell Death Differ.
<volume>13</volume>, <fpage>20</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4401706</pub-id><pub-id pub-id-type="pmid">16021180</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Romero-Carvajal</surname><given-names>A.</given-names></name><name><surname>Haug</surname><given-names>J. S.</given-names></name><name><surname>Seidel</surname><given-names>C. W.</given-names></name><name><surname>Piotrowski</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Gene-expression analysis of hair cell regeneration in the zebrafish lateral line</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>111</volume>, <fpage>E1383</fpage>–<lpage>E1392</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1402898111</pub-id><pub-id pub-id-type="pmid">24706903</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karasawa</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>David</surname><given-names>L. L.</given-names></name><name><surname>Steyger</surname><given-names>P. S.</given-names></name></person-group> (<year>2010</year>). <article-title>CLIMP-63 is a gentamicin-binding protein that is involved in drug-induced cytotoxicity</article-title>. <source/>Cell Death Dis.
<volume>1</volume>:<fpage>e102</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2010.80</pub-id><pub-id pub-id-type="pmid">21368867</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karasawa</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>David</surname><given-names>L. L.</given-names></name><name><surname>Steyger</surname><given-names>P. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Calreticulin binds to gentamicin and reduces drug-induced ototoxicity</article-title>. <source/>Toxicol. Sci.
<volume>124</volume>, <fpage>378</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfr196</pub-id><pub-id pub-id-type="pmid">21785162</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kari</surname><given-names>G.</given-names></name><name><surname>Rodeck</surname><given-names>U.</given-names></name><name><surname>Dicker</surname><given-names>A. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Zebrafish: an emerging model system for human disease and drug discovery</article-title>. <source/>Clin. Pharmacol. Ther.
<volume>82</volume>, <fpage>70</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/sj.clpt.6100223</pub-id><pub-id pub-id-type="pmid">17495877</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaul</surname><given-names>M.</given-names></name><name><surname>Pilch</surname><given-names>D. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Thermodynamics of aminoglycoside-rRNA recognition: the binding of neomycin-class aminoglycosides to the A site of 16S rRNA</article-title>. <source/>Biochemistry
<volume>41</volume>, <fpage>7695</fpage>–<lpage>7706</lpage>. <pub-id pub-id-type="doi">10.1021/bi020130f</pub-id><pub-id pub-id-type="pmid">12056901</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>Y.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Aizawa</surname><given-names>H.</given-names></name><name><surname>Kanazawa</surname><given-names>I.</given-names></name><name><surname>Kwak</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Glutamate receptors: RNA editing and death of motor neurons</article-title>. <source/>Nature
<volume>427</volume>:<fpage>801</fpage>. <pub-id pub-id-type="doi">10.1038/427801a</pub-id><pub-id pub-id-type="pmid">14985749</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmel</surname><given-names>C. B.</given-names></name><name><surname>Ballard</surname><given-names>W. W.</given-names></name><name><surname>Kimmel</surname><given-names>S. R.</given-names></name><name><surname>Ullmann</surname><given-names>B.</given-names></name><name><surname>Schilling</surname><given-names>T. F.</given-names></name></person-group> (<year>1995</year>). <article-title>Stages of embryonic development of the zebrafish</article-title>. <source/>Dev. Dyn.
<volume>203</volume>, <fpage>253</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1002/aja.1002030302</pub-id><pub-id pub-id-type="pmid">8589427</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiran</surname><given-names>A.</given-names></name><name><surname>Baranov</surname><given-names>P. V.</given-names></name></person-group> (<year>2010</year>). <article-title>DARNED: a DAtabase of RNa EDiting in humans</article-title>. <source/>Bioinformatics
<volume>26</volume>, <fpage>1772</fpage>–<lpage>1776</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq285</pub-id><pub-id pub-id-type="pmid">20547637</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klaue</surname><given-names>Y.</given-names></name><name><surname>Källman</surname><given-names>A. M.</given-names></name><name><surname>Bonin</surname><given-names>M.</given-names></name><name><surname>Nellen</surname><given-names>W.</given-names></name><name><surname>Ohman</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Biochemical analysis and scanning force microscopy reveal productive and nonproductive ADAR2 binding to RNA substrates</article-title>. <source/>RNA
<volume>9</volume>, <fpage>839</fpage>–<lpage>846</lpage>. <pub-id pub-id-type="doi">10.1261/rna.2167603</pub-id><pub-id pub-id-type="pmid">12810917</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>K. A.</given-names></name><name><surname>Bass</surname><given-names>B. L.</given-names></name></person-group> (<year>1999</year>). <article-title>The importance of internal loops within RNA substrates of ADAR1</article-title>. <source/>J. Mol. Biol.
<volume>291</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.1999.2914</pub-id><pub-id pub-id-type="pmid">10438602</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leitner</surname><given-names>M. G.</given-names></name><name><surname>Halaszovich</surname><given-names>C. R.</given-names></name><name><surname>Oliver</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate</article-title>. <source/>Mol. Pharmacol.
<volume>79</volume>, <fpage>51</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1124/mol.110.068130</pub-id><pub-id pub-id-type="pmid">20935082</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Durbin</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Fast and accurate short read alignment with Burrows–Wheeler transform</article-title>. <source/>Bioinformatics
<volume>25</volume>, <fpage>1754</fpage>–<lpage>1760</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id><pub-id pub-id-type="pmid">19451168</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Handsaker</surname><given-names>B.</given-names></name><name><surname>Wysoker</surname><given-names>A.</given-names></name><name><surname>Fennell</surname><given-names>T.</given-names></name><name><surname>Ruan</surname><given-names>J.</given-names></name><name><surname>Homer</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>The sequence alignment/map format and SAMtools</article-title>. <source/>Bioinformatics
<volume>25</volume>, <fpage>2078</fpage>–<lpage>2079</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>I. C.</given-names></name><name><surname>Chen</surname><given-names>Y.-C.</given-names></name><name><surname>Wang</surname><given-names>Y.-Y.</given-names></name><name><surname>Tzeng</surname><given-names>B.-W.</given-names></name><name><surname>Ou</surname><given-names>C.-W.</given-names></name><name><surname>Lau</surname><given-names>Y.-Y.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Zebrafish Adar2 edits the Q/R site of AMPA receptor subunit gria2α transcript to ensure normal development of nervous system and cranial neural crest cells</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e97133</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0097133</pub-id><pub-id pub-id-type="pmid">24818983</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Liao</surname><given-names>Z.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Qian</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss</article-title>. <source/>Hum. Genet.
<volume>117</volume>, <fpage>9</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-005-1276-1</pub-id><pub-id pub-id-type="pmid">15841390</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maas</surname><given-names>S.</given-names></name><name><surname>Kawahara</surname><given-names>Y.</given-names></name><name><surname>Tamburro</surname><given-names>K. M.</given-names></name><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>A-to-I RNA editing and human disease</article-title>. <source/>RNA Biol.
<volume>3</volume>, <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4161/rna.3.1.2495</pub-id><pub-id pub-id-type="pmid">17114938</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehler</surname><given-names>M. F.</given-names></name><name><surname>Mattick</surname><given-names>J. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease</article-title>. <source/>Physiol. Rev.
<volume>87</volume>, <fpage>799</fpage>–<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00036.2006</pub-id><pub-id pub-id-type="pmid">17615389</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>H.</given-names></name><name><surname>Poudel</surname><given-names>S.</given-names></name><name><surname>Muruganujan</surname><given-names>A.</given-names></name><name><surname>Casagrande</surname><given-names>J. T.</given-names></name><name><surname>Thomas</surname><given-names>P. D.</given-names></name></person-group> (<year>2016</year>). <article-title>PANTHER version 10: expanded protein families and functions, and analysis tools</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>D336</fpage>–<lpage>D342</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1194</pub-id><pub-id pub-id-type="pmid">26578592</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>W. J.</given-names></name><name><surname>Nusse</surname><given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>Convergence of Wnt, beta-catenin, and cadherin pathways</article-title>. <source/>Science
<volume>303</volume>, <fpage>1483</fpage>–<lpage>1487</lpage>. <pub-id pub-id-type="doi">10.1126/science.1094291</pub-id><pub-id pub-id-type="pmid">15001769</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolson</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>The genetics of hearing and balance in zebrafish</article-title>. <source/>Annu. Rev. Genet.
<volume>39</volume>, <fpage>9</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.genet.39.073003.105049</pub-id><pub-id pub-id-type="pmid">16285850</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Functions and regulation of RNA editing by ADAR deaminases</article-title>. <source/>Annu. Rev. Biochem.
<volume>79</volume>, <fpage>321</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-060208-105251</pub-id><pub-id pub-id-type="pmid">20192758</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oganesian</surname><given-names>A.</given-names></name><name><surname>Poot</surname><given-names>M.</given-names></name><name><surname>Daum</surname><given-names>G.</given-names></name><name><surname>Coats</surname><given-names>S. A.</given-names></name><name><surname>Wright</surname><given-names>M. B.</given-names></name><name><surname>Seifert</surname><given-names>R. A.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>100</volume>, <fpage>7563</fpage>–<lpage>7568</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1336511100</pub-id><pub-id pub-id-type="pmid">12802008</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>K. N.</given-names></name><name><surname>Coffin</surname><given-names>A. B.</given-names></name><name><surname>Hong</surname><given-names>L. S.</given-names></name><name><surname>Bennett</surname><given-names>K. O. C.</given-names></name><name><surname>Rubel</surname><given-names>E. W.</given-names></name><name><surname>Raible</surname><given-names>D. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Response of mechanosensory hair cells of the zebrafish lateral line to aminoglycosides reveals distinct cell death pathways</article-title>. <source/>Hear. Res.
<volume>253</volume>, <fpage>32</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.heares.2009.03.001</pub-id><pub-id pub-id-type="pmid">19285126</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palladino</surname><given-names>M. J.</given-names></name><name><surname>Keegan</surname><given-names>L. P.</given-names></name><name><surname>O'Connell</surname><given-names>M. A.</given-names></name><name><surname>Reenan</surname><given-names>R. A.</given-names></name></person-group> (<year>2000</year>). <article-title>A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity</article-title>. <source/>Cell
<volume>102</volume>, <fpage>437</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)00049-0</pub-id><pub-id pub-id-type="pmid">10966106</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z.</given-names></name><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>B. C.-M.</given-names></name><name><surname>Kang</surname><given-names>L.</given-names></name><name><surname>Tian</surname><given-names>Z.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome</article-title>. <source/>Nat. Biotechnol.
<volume>30</volume>, <fpage>253</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2122</pub-id><pub-id pub-id-type="pmid">22327324</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirvola</surname><given-names>U.</given-names></name><name><surname>Spencer-Dene</surname><given-names>B.</given-names></name><name><surname>Xing-Qun</surname><given-names>L.</given-names></name><name><surname>Kettunen</surname><given-names>P.</given-names></name><name><surname>Thesleff</surname><given-names>I.</given-names></name><name><surname>Fritzsch</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>FGF/FGFR-2(IIIb) signaling is essential for inner ear morphogenesis</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>6125</fpage>–<lpage>6134</lpage>. <pub-id pub-id-type="pmid">10934262</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirvola</surname><given-names>U.</given-names></name><name><surname>Ylikoski</surname><given-names>J.</given-names></name><name><surname>Trokovic</surname><given-names>R.</given-names></name><name><surname>Hébert</surname><given-names>J. M.</given-names></name><name><surname>McConnell</surname><given-names>S. K.</given-names></name><name><surname>Partanen</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>FGFR1 is required for the development of the auditory sensory epithelium</article-title>. <source/>Neuron
<volume>35</volume>, <fpage>671</fpage>–<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(02)00824-3</pub-id><pub-id pub-id-type="pmid">12194867</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porath</surname><given-names>H. T.</given-names></name><name><surname>Carmi</surname><given-names>S.</given-names></name><name><surname>Levanon</surname><given-names>E. Y.</given-names></name></person-group> (<year>2014</year>). <article-title>A genome-wide map of hyper-edited RNA reveals numerous new sites</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>4726</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms5726</pub-id><pub-id pub-id-type="pmid">25158696</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozo</surname><given-names>P.</given-names></name><name><surname>Hoopengardner</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Identification and characterization of two novel RNA editing sites in grin1b transcripts of embryonic <italic>Danio rerio</italic></article-title>. <source/>Neural Plast.
<volume>2012</volume>:<fpage>173728</fpage>. <pub-id pub-id-type="doi">10.1155/2012/173728</pub-id><pub-id pub-id-type="pmid">22530154</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Xiong</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Single-cell RNA sequencing reveals dynamic changes in A-to-I RNA editome during early human embryogenesis</article-title>. <source/>BMC Genomics
<volume>17</volume>:<fpage>766</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-016-3115-2</pub-id><pub-id pub-id-type="pmid">27687780</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group> (<year>2013</year>). <article-title>R: a language and environment for statistical computing</article-title>. <source/>Computing
<volume>1</volume>, <fpage>12</fpage>–<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raible</surname><given-names>F.</given-names></name><name><surname>Brand</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Tight transcriptional control of the ETS domain factors Erm and Pea3 by Fgf signaling during early zebrafish development</article-title>. <source/>Mech. Dev.
<volume>107</volume>, <fpage>105</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/S0925-4773(01)00456-7</pub-id><pub-id pub-id-type="pmid">11520667</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaswami</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Piskol</surname><given-names>R.</given-names></name><name><surname>Keegan</surname><given-names>L. P.</given-names></name><name><surname>Deng</surname><given-names>P.</given-names></name><name><surname>O'Connell</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Identifying RNA editing sites using RNA sequencing data alone</article-title>. <source/>Nat. Methods
<volume>10</volume>, <fpage>128</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2330</pub-id><pub-id pub-id-type="pmid">23291724</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzi</surname><given-names>M. D.</given-names></name><name><surname>Hirose</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Aminoglycoside ototoxicity</article-title>. <source/>Curr. Opin. Otolaryngol. Head Neck Surg.
<volume>15</volume>, <fpage>352</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1097/MOO.0b013e3282ef772d</pub-id><pub-id pub-id-type="pmid">17823553</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rybak</surname><given-names>L. P.</given-names></name><name><surname>Ramkumar</surname><given-names>V.</given-names></name></person-group> (<year>2007</year>). <article-title>Ototoxicity</article-title>. <source/>Kidney Int.
<volume>72</volume>, <fpage>931</fpage>–<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ki.5002434</pub-id><pub-id pub-id-type="pmid">17653135</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>F.</given-names></name><name><surname>MacDonald</surname><given-names>G.</given-names></name><name><surname>Rubel</surname><given-names>E. W.</given-names></name><name><surname>Raible</surname><given-names>D. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Lateral line hair cell maturation is a determinant of aminoglycoside susceptibility in zebrafish (<italic>Danio rerio</italic>)</article-title>. <volume>213</volume>, <fpage>25</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.heares.2005.12.009</pub-id><pub-id pub-id-type="pmid">16459035</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scaglione</surname><given-names>F.</given-names></name><name><surname>Vigano</surname><given-names>A.</given-names></name><name><surname>Colucci</surname><given-names>R.</given-names></name><name><surname>Zampaglione</surname><given-names>N.</given-names></name><name><surname>Lin</surname><given-names>C. C.</given-names></name><name><surname>Cutler</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>Pharmacokinetics of isepamicin in paediatric patients</article-title>. <source/>J. Chemother.
<volume>7</volume>(<issue>Suppl. 2</issue>), <fpage>63</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="pmid">8622112</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schatz</surname><given-names>A.</given-names></name><name><surname>Waksman</surname><given-names>S. A.</given-names></name></person-group> (<year>1944</year>). <article-title>Effect of streptomycin and other antibiotic substances upon <italic>Mycobacterium tuberculosis</italic> and related organisms</article-title>. <source/>Exp. Biol. Med.
<volume>57</volume>, <fpage>244</fpage>–<lpage>248</lpage>.</mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirle</surname><given-names>N. T.</given-names></name><name><surname>Goodman</surname><given-names>R. A.</given-names></name><name><surname>Krishnamurthy</surname><given-names>M.</given-names></name><name><surname>Beal</surname><given-names>P. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Selective inhibition of ADAR2-catalyzed editing of the serotonin 2c receptor pre-mRNA by a helix-threading peptide</article-title>. <source/>Organ. Biomol. Chem.
<volume>8</volume>, <fpage>4898</fpage>–<lpage>4904</lpage>. <pub-id pub-id-type="doi">10.1039/c0ob00309c</pub-id><pub-id pub-id-type="pmid">20820662</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seiler</surname><given-names>C.</given-names></name><name><surname>Nicolson</surname><given-names>T.</given-names></name></person-group> (<year>1999</year>). <article-title>Defective calmodulin-dependent rapid apical endocytosis in zebrafish sensory hair cell mutants</article-title>. <source/>J. Neurobiol.
<volume>41</volume>, <fpage>424</fpage>–<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1097-4695(19991115)41:3&lt;424::aid-neu10&gt;3.3.co;2-7</pub-id><pub-id pub-id-type="pmid">10526320</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>S. P.</given-names></name><name><surname>Morin</surname><given-names>R. D.</given-names></name><name><surname>Khattra</surname><given-names>J.</given-names></name><name><surname>Prentice</surname><given-names>L.</given-names></name><name><surname>Pugh</surname><given-names>T.</given-names></name><name><surname>Burleigh</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution</article-title>. <source/>Nature
<volume>461</volume>, <fpage>809</fpage>–<lpage>813</lpage>. <pub-id pub-id-type="doi">10.1038/nature08489</pub-id><pub-id pub-id-type="pmid">19812674</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamay-Ramot</surname><given-names>A.</given-names></name><name><surname>Khermesh</surname><given-names>K.</given-names></name><name><surname>Porath</surname><given-names>H. T.</given-names></name><name><surname>Barak</surname><given-names>M.</given-names></name><name><surname>Pinto</surname><given-names>Y.</given-names></name><name><surname>Wachtel</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Fmrp interacts with adar and regulates RNA editing, synaptic density and locomotor activity in zebrafish</article-title>. <source/>PLoS Genet.
<volume>11</volume>:<fpage>e1005702</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1005702</pub-id><pub-id pub-id-type="pmid">26637167</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sie</surname><given-names>C. P.</given-names></name><name><surname>Maas</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Conserved recoding RNA editing of vertebrate C1q-related factor C1QL1</article-title>. <source/>FEBS Lett.
<volume>583</volume>, <fpage>1171</fpage>–<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2009.02.044</pub-id><pub-id pub-id-type="pmid">19275900</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sone</surname><given-names>M.</given-names></name><name><surname>Schachern</surname><given-names>P. A.</given-names></name><name><surname>Paparella</surname><given-names>M. M.</given-names></name></person-group> (<year>1998</year>). <article-title>Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity</article-title>. <source/>Hear. Res.
<volume>115</volume>, <fpage>217</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-5955(97)00191-3</pub-id><pub-id pub-id-type="pmid">9472750</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamatiou</surname><given-names>G. A.</given-names></name><name><surname>Stankovic</surname><given-names>K. M.</given-names></name></person-group> (<year>2013</year>). <article-title>A comprehensive network and pathway analysis of human deafness genes</article-title>. <source/>Otol. Neurotol.
<volume>34</volume>, <fpage>961</fpage>–<lpage>970</lpage>. <pub-id pub-id-type="doi">10.1097/MAO.0b013e3182898272</pub-id><pub-id pub-id-type="pmid">23770690</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>A. B.</given-names></name><name><surname>Kim</surname><given-names>T.</given-names></name><name><surname>Cabot</surname><given-names>V.</given-names></name><name><surname>Hudspeth</surname><given-names>A. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Dynamic gene expression by putative hair-cell progenitors during regeneration in the zebrafish lateral line</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>111</volume>, <fpage>E1393</fpage>–<lpage>E1401</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1318692111</pub-id><pub-id pub-id-type="pmid">24706895</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stengel</surname><given-names>D.</given-names></name><name><surname>Zindler</surname><given-names>F.</given-names></name><name><surname>Braunbeck</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>An optimized method to assess ototoxic effects in the lateral line of zebrafish (<italic>Danio rerio</italic>) embryos</article-title>. <source/>Comp. Biochem. Physiol. C Toxicol. Pharmacol.
<volume>193</volume>, <fpage>18</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpc.2016.11.001</pub-id><pub-id pub-id-type="pmid">27847309</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stiburek</surname><given-names>L.</given-names></name><name><surname>Fornuskova</surname><given-names>D.</given-names></name><name><surname>Wenchich</surname><given-names>L.</given-names></name><name><surname>Pejznochova</surname><given-names>M.</given-names></name><name><surname>Hansikova</surname><given-names>H.</given-names></name><name><surname>Zeman</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Knockdown of human Oxa1l impairs the biogenesis of F1Fo-ATP synthase and NADH:ubiquinone oxidoreductase</article-title>. <source/>J. Mol. Biol.
<volume>374</volume>, <fpage>506</fpage>–<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2007.09.044</pub-id><pub-id pub-id-type="pmid">17936786</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St Laurent</surname><given-names>G.</given-names></name><name><surname>Tackett</surname><given-names>M. R.</given-names></name><name><surname>Nechkin</surname><given-names>S.</given-names></name><name><surname>Shtokalo</surname><given-names>D.</given-names></name><name><surname>Antonets</surname><given-names>D.</given-names></name><name><surname>Savva</surname><given-names>Y. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Genome-wide analysis of A-to-I RNA editing by single-molecule sequencing in Drosophila</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>20</volume>, <fpage>1333</fpage>–<lpage>1339</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2675</pub-id><pub-id pub-id-type="pmid">24077224</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C.</given-names></name><name><surname>Roberts</surname><given-names>A.</given-names></name><name><surname>Goff</surname><given-names>L.</given-names></name><name><surname>Pertea</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Kelley</surname><given-names>D. R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and cufflinks</article-title>. <source/>Nat. Protoc.
<volume>7</volume>, <fpage>562</fpage>–<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2012.016</pub-id><pub-id pub-id-type="pmid">22383036</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vacic</surname><given-names>V.</given-names></name><name><surname>Iakoucheva</surname><given-names>L. M.</given-names></name><name><surname>Radivojac</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Two sample logo: a graphical representation of the differences between two sets of sequence alignments</article-title>. <source/>Bioinformatics
<volume>22</volume>, <fpage>1536</fpage>–<lpage>1537</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btl151</pub-id><pub-id pub-id-type="pmid">16632492</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Wesenbeeck</surname><given-names>L.</given-names></name><name><surname>Odgren</surname><given-names>P. R.</given-names></name><name><surname>Coxon</surname><given-names>F. P.</given-names></name><name><surname>Frattini</surname><given-names>A.</given-names></name><name><surname>Moens</surname><given-names>P.</given-names></name><name><surname>Perdu</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Involvement of <italic>PLEKHM1</italic> in osteoclastic vesicular transport and osteopetrosis in <italic>incisors absent</italic> rats and humans</article-title>. <source/>J. Clin. Invest.
<volume>117</volume>, <fpage>919</fpage>–<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1172/JCI30328</pub-id><pub-id pub-id-type="pmid">17404618</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vemaraju</surname><given-names>S.</given-names></name><name><surname>Kantarci</surname><given-names>H.</given-names></name><name><surname>Padanad</surname><given-names>M. S.</given-names></name><name><surname>Riley</surname><given-names>B. B.</given-names></name></person-group> (<year>2012</year>). <article-title>A spatial and temporal gradient of Fgf differentially regulates distinct stages of neural development in the zebrafish inner ear</article-title>. <source/>PLoS Genet.
<volume>8</volume>:<fpage>e1003068</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1003068</pub-id><pub-id pub-id-type="pmid">23166517</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicens</surname><given-names>Q.</given-names></name><name><surname>Westhof</surname><given-names>E.</given-names></name></person-group> (<year>2003</year>). <article-title>RNA as a drug target: the case of aminoglycosides</article-title>. <source/>Chembiochem
<volume>4</volume>, <fpage>1018</fpage>–<lpage>1023</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.200300684</pub-id><pub-id pub-id-type="pmid">14523919</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>I. X.</given-names></name><name><surname>So</surname><given-names>E.</given-names></name><name><surname>Devlin</surname><given-names>J. L.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Cheung</surname><given-names>V. G.</given-names></name></person-group> (<year>2013</year>). <article-title>ADAR regulates RNA editing, transcript stability, and gene expression</article-title>. <source/>Cell Rep.
<volume>5</volume>, <fpage>849</fpage>–<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.10.002</pub-id><pub-id pub-id-type="pmid">24183664</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>F.</given-names></name><name><surname>Dong</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Fgf-signaling-dependent Sox9a and Atoh1a regulate otic neural development in zebrafish</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>234</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3353-14.2015</pub-id><pub-id pub-id-type="pmid">25568117</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Westerfield</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <source/>The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio). Zebrafish Book A Guide for the Laboratory Use of Zebrafish. <publisher-loc>Eugene, OR</publisher-loc>: <publisher-name>University of Oregon Press</publisher-name>.</mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitfield</surname><given-names>T. T.</given-names></name><name><surname>Riley</surname><given-names>B. B.</given-names></name><name><surname>Chiang</surname><given-names>M. Y.</given-names></name><name><surname>Phillips</surname><given-names>B.</given-names></name></person-group> (<year>2002</year>). <article-title>Development of the zebrafish inner ear</article-title>. <source/>Dev. Dyn.
<volume>223</volume>, <fpage>427</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.10073</pub-id><pub-id pub-id-type="pmid">11921334</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S. K.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><name><surname>Lazinski</surname><given-names>D. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Substrate recognition by ADAR1 and ADAR2</article-title>. <source/>RNA
<volume>7</volume>, <fpage>846</fpage>–<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1017/S135583820101007X</pub-id><pub-id pub-id-type="pmid">11421361</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>M. B.</given-names></name><name><surname>Hugo</surname><given-names>C.</given-names></name><name><surname>Seifert</surname><given-names>R.</given-names></name><name><surname>Disteche</surname><given-names>C. M.</given-names></name><name><surname>Bowen-Pope</surname><given-names>D. F.</given-names></name></person-group> (<year>1998</year>). <article-title>Proliferating and migrating mesangial cells responding to injury express a novel receptor protein-tyrosine phosphatase in experimental mesangial proliferative glomerulonephritis</article-title>. <source/>J. Biol. Chem.
<volume>273</volume>, <fpage>23929</fpage>–<lpage>23937</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.37.23929</pub-id><pub-id pub-id-type="pmid">9727007</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>S.</given-names></name><name><surname>Xing</surname><given-names>Q.</given-names></name><name><surname>Tian</surname><given-names>W.</given-names></name></person-group> (<year>2017</year>). <article-title>SPRINT: an SNP-free toolkit for identifying RNA editing sites</article-title>. <source/>Bioinformatics
<volume>33</volume>, <fpage>3538</fpage>–<lpage>3548</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx473</pub-id><pub-id pub-id-type="pmid">29036410</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>